Publications
2024
Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility.
Henry-Blake, C., Balachandrakumar, V., Kassab, M., Devonport, J., Matthews, C., Fox, J., . . . Cross, T. J. S. (2024). Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility.. Journal of gastroenterology and hepatology. doi:10.1111/jgh.16727
Progression of Chronic Liver Disease to Hepatocellular Carcinoma: Implications for Surveillance and Management
Johnson, P. (n.d.). Progression of Chronic Liver Disease to Hepatocellular Carcinoma: Implications for Surveillance and Management. BJ Cancer Reports.
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma.
Toyoda, H., Kanneganti, M., Melendez-Torres, J., Parikh, N. D., Jalal, P. K., Piñero, F., . . . Johnson, P. J. (2024). Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 22(1), 72-80.e4. doi:10.1016/j.cgh.2023.06.026
Serologic Detection of Hepatocellular Carcinoma: Application of Machine Learning and Implications for Diagnostic Models.
Johnson, P. J., Bhatti, E., Toyoda, H., & He, S. (2024). Serologic Detection of Hepatocellular Carcinoma: Application of Machine Learning and Implications for Diagnostic Models.. JCO clinical cancer informatics, 8, e2300199. doi:10.1200/cci.23.00199
2023
European' health care indicators and pancreatic cancer incidence and mortality: A mediation analysis of Eurostat data and Global Burden of Disease Study 2019.
Cucchetti, A., Johnson, P., Capurso, G., Crippa, S., Pacilio, C. A., Fabbri, C., . . . Ercolani, G. (2023). European' health care indicators and pancreatic cancer incidence and mortality: A mediation analysis of Eurostat data and Global Burden of Disease Study 2019.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 23(7), 829-835. doi:10.1016/j.pan.2023.09.001
Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score
Truong, T. N., Pham, T. N. D., Hoang, L. B., Nguyen, V. T., Dao, H. V., Dao, D. V. B., . . . Dao, D. Y. (2023). Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score. BMC CANCER, 23(1). doi:10.1186/s12885-023-11167-9
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study
Hamill, V., Wong, S., Benselin, J., Krajden, M., Hayes, P. C., Mutimer, D., . . . Innes, H. (2023). Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study. BMJ-BRITISH MEDICAL JOURNAL, 382. doi:10.1136/bmj-2022-074001
Exploration of the lack of systematic surveillance for hepatocellular carcinoma for patients with non-alcoholic fatty liver disease
Hydes, T., Blake, C. H., Kassab, M., Matthews, C., Kumar, V., Baggus, E., . . . Cross, T. (2023). Exploration of the lack of systematic surveillance for hepatocellular carcinoma for patients with non-alcoholic fatty liver disease. Journal of Hepatology, 78, S521-S522. doi:10.1016/s0168-8278(23)01278-3
'Potentially curative therapies' for hepatocellular carcinoma: how many patients can actually be cured?
Cucchetti, A., Elshaarawy, O., Han, G., Chong, C. C. N., Serra, C., O'Rourke, J. M., . . . Johnson, P. J. (2023). 'Potentially curative therapies' for hepatocellular carcinoma: how many patients can actually be cured?. BRITISH JOURNAL OF CANCER, 128(9), 1665-1671. doi:10.1038/s41416-023-02188-z
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma
Mosconi, C., O'Rourke, J., Kloeckner, R., Sturm, L., Golfieri, R., Celsa, C., . . . Cucchetti, A. (2023). Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular Carcinoma. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 46(4), 449-459. doi:10.1007/s00270-023-03375-4
Predictive and prognostic potential of liver function assessment in patients with advanced hepatocellular carcinoma: a systematic literature review
Vogel, A., Kelley, R. K., Johnson, P., Merle, P., Yau, T., Kudo, M., . . . Rimassa, L. (2023). Predictive and prognostic potential of liver function assessment in patients with advanced hepatocellular carcinoma: a systematic literature review. LIVER CANCER, 12(4), 372-391. doi:10.1159/000529173
Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
Hydes, T. J., Cuthbertson, D. J., Palmer, D. H., Elshaarawy, O., Johnson, P. J., Fernando, R., & Cross, T. J. (2023). Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. HEPATOMA RESEARCH, 9. doi:10.20517/2394-5079.2022.97
2022
Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify
Johnson, P. J., Innes, H., Hughes, D. M., Kalyuzhnyy, A., Kumada, T., & Toyoda, H. (2022). Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify. BRITISH JOURNAL OF CANCER, 127(7), 1263-1269. doi:10.1038/s41416-022-01851-1
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
Johnson, P., Zhou, Q., Dao, D. Y., & Lo, Y. M. D. (2022). Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 19(10), 670-681. doi:10.1038/s41575-022-00620-y
The ALBI score: From liver function in patients with HCC to a general measure of liver function
Toyoda, H., & Johnson, P. J. (2022). The ALBI score: From liver function in patients with HCC to a general measure of liver function. JHEP REPORTS, 4(10). doi:10.1016/j.jhepr.2022.100557
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?
Innes, H., Hamill, V., McDonald, S. A., Hayes, P. C., Johnson, P., Dillon, J. F., . . . Hutchinson, S. J. (2022). Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?. AMERICAN JOURNAL OF GASTROENTEROLOGY, 117(9), 1454-1461. doi:10.14309/ajg.0000000000001879
LACK OF NAFLD-RELATED HEPATOCELLULAR CARCINOMA SURVEILLANCE MAY EXPLAIN MORE ADVANCED STAGE AT DIAGNOSIS AND WORSE MEDIAN SURVIVAL
Hydes, T., Matthews, C., Kumar, V., Kassab, M., Blake, C. H., Baggus, E., . . . Cross, T. (2022). LACK OF NAFLD-RELATED HEPATOCELLULAR CARCINOMA SURVEILLANCE MAY EXPLAIN MORE ADVANCED STAGE AT DIAGNOSIS AND WORSE MEDIAN SURVIVAL. In GUT Vol. 71 (pp. A46-A47). doi:10.1136/gutjnl-2022-BASL.72
Improved survival of viral hepatocellular carcinoma but non-viral hepatocellular carcinoma from 2000 to 2020: A multicenter cohort study of 6007 patients from high-volume academic centers in Japan
Toyoda, H., Kariyama, K., Hiraoka, A., Tsuji, K., Ishikawa, T., Hatanaka, T., . . . Johnson, P. J. (2022). Improved survival of viral hepatocellular carcinoma but non-viral hepatocellular carcinoma from 2000 to 2020: A multicenter cohort study of 6007 patients from high-volume academic centers in Japan. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 56(4), 694-701. doi:10.1111/apt.17088
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
Kudo, M., Ueshima, K., Ikeda, M., Torimura, T., Tanabe, N., Aikata, H., . . . Arai, Y. (2022). Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarteria Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma. LIVER CANCER, 11(4), 354-367. doi:10.1159/000522547
Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma comment
Johnson, P. J., Pinato, D. J., Kalyuzhnyy, A., & Toyoda, H. (2022). Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma comment. JOURNAL OF CLINICAL ONCOLOGY, 40(19), 2078-+. doi:10.1200/JCO.21.02373
Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis
Mishra, G., Majeed, A., Dev, A., Eslick, G. D., Pinato, D. J., Izumoto, H., . . . Roberts, S. K. (2022). Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis. JOURNAL OF GASTROINTESTINAL CANCER. doi:10.1007/s12029-022-00832-0
Sorafenib is associated with reduced tumour growth rate and liver function deterioration in HCV-induced hepatocellular carcinoma
Kolamunnage-Dona, R., & Johnson, P. (2022). Sorafenib is associated with reduced tumour growth rate and liver function deterioration in HCV-induced hepatocellular carcinoma. Journal of Hepatology.
Obituary for Dr. Ian G. McFarlane and Dr. Barbara McFarlane Obituary Obituary
Johnson, P. J. (2022). Obituary for Dr. Ian G. McFarlane and Dr. Barbara McFarlane Obituary Obituary. JOURNAL OF HEPATOLOGY, 77(2), 277. doi:10.1016/j.jhep.2022.04.017
The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival
Hydes, T. J., Cuthbertson, D. J., Graef, S., Berhane, S., Teng, M., Skowronska, A., . . . Johnson, P. J. (2022). The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival. Clinical Therapeutics. doi:10.1016/j.clinthera.2021.12.011
Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making.
Innes, H., Johnson, P., McDonald, S. A., Hamill, V., Yeung, A., Dillon, J. F., . . . Hutchinson, S. J. (2022). Competing Risk Bias in Prognostic Models Predicting Hepatocellular Carcinoma Occurrence: Impact on Clinical Decision-making.. Gastro hep advances, 1(2), 129-136. doi:10.1016/j.gastha.2021.11.008
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., . . . Manns, M. P. (2022). The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. LANCET, 399(10319), 61-116. doi:10.1016/S0140-6736(21)01701-3
2021
Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre study
Zhong, J. -H., Xing, B. -C., Zhang, W. -G., Chan, A. W. -H., Chong, C. C. N., Serenari, M., . . . Xiang, B. -D. (2022). Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre study. BRITISH JOURNAL OF SURGERY, 109(1), 71-78. doi:10.1093/bjs/znab340
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection
Innes, H., Jepsen, P., McDonald, S., Dillon, J., Hamill, V., Yeung, A., . . . Guha, I. N. (2021). Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection. JHEP REPORTS, 3(6). doi:10.1016/j.jhepr.2021.100384
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment
Cucchetti, A., Gramenzi, A., Johnson, P., Giannini, E. G., Tovoli, F., Rapaccini, G. L., . . . Romagnoli, V. (2021). Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment. European Journal of Cancer, 158, 133-143. doi:10.1016/j.ejca.2021.09.018
Characterisation of dysplastic liver nodules using low-pass DNA sequencing and detection of chromosome arm-level abnormalities in blood-derived cell-free DNA
Fateen, W., Johnson, P. J., Wood, H. M., Zhang, H., He, S., El-Meteini, M., . . . Quirke, P. (2021). Characterisation of dysplastic liver nodules using low-pass DNA sequencing and detection of chromosome arm-level abnormalities in blood-derived cell-free DNA. JOURNAL OF PATHOLOGY, 255(1), 30-40. doi:10.1002/path.5734
Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis
Edeline, J., Lamarca, A., McNamara, M. G., Jacobs, T., Hubner, R. A., Palmer, D., . . . Valle, J. W. (2021). Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis. CANCER TREATMENT REVIEWS, 99. doi:10.1016/j.ctrv.2021.102258
The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study
Johnson, P. J., Dhanaraj, S., Berhane, S., Bonnett, L., & Ma, Y. T. (2021). The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study. BRITISH JOURNAL OF CANCER, 125(5), 714-716. doi:10.1038/s41416-021-01445-3
GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients
Schotten, C., Ostertag, B., Sowa, J. -P., Manka, P., Bechmann, L. P., Hilgard, G., . . . Best, J. (n.d.). GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients. Pharmaceuticals, 14(8), 735. doi:10.3390/ph14080735
Systematic review and pooled analysis of locoregional therapies in patients with intrahepatic cholangiocarcinoma
Edeline, J., Lamarca, A., McNamara, M., Jacobs, T., Hubner, R., Palmer, D., . . . Valle, J. (2021). Systematic review and pooled analysis of locoregional therapies in patients with intrahepatic cholangiocarcinoma. In ANNALS OF ONCOLOGY Vol. 32 (pp. S177). doi:10.1016/j.annonc.2021.05.283
Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C Virus
Kumada, T., Toyoda, H., Yasuda, S., Tada, T., Tanaka, J., Chayama, K., . . . Irving, W. L. (2021). Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C Virus. INFECTIOUS DISEASES AND THERAPY, 10(2), 1001-1013. doi:10.1007/s40121-021-00441-7
In search of an evidence base for HCC surveillance: Purity or pragmatism?
Johnson, P. J. (2021). In search of an evidence base for HCC surveillance: Purity or pragmatism?. JOURNAL OF HEPATOLOGY, 74(5), 1025-1027. doi:10.1016/j.jhep.2021.02.018
Impact Of Direct Acting Antiviral Agents On Liver Function In Patients With Chronic Hepatitis C Virus Infection.
Johnson, P. J., Berhane, S., Walker, A. J., Gordon, F. H., Ryder, S. D., McPherson, S., . . . Irving, W. L. (2021). Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection. JOURNAL OF VIRAL HEPATITIS, 28(1), 168-176. doi:10.1111/jvh.13408
2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Fan, R., Papatheodoridis, G., Sun, J., Innes, H., Toyoda, H., Xie, Q., . . . Hou, J. (2020). aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. JOURNAL OF HEPATOLOGY, 73(6), 1368-1378. doi:10.1016/j.jhep.2020.07.025
AFP is elevated more than 10 years before hepatocellular carcinoma development is detected: this observation leads to a practical risk stratification strategy
Johnson, P., Berhane, S., de Groot, E., Toyoda, H., Tada, T., Kumada, T., . . . Hughes, D. M. (2020). AFP is elevated more than 10 years before hepatocellular carcinoma development is detected: this observation leads to a practical risk stratification strategy. Journal of Hepatology, 73, S387-S388. doi:10.1016/s0168-8278(20)31265-4
Quantitative assessment of the impact of viral state on the rate of tumour progression in patients receiving sorafenib for advanced hepatocellular carcinoma
Johnson, P., Berhane, S., & Kolamunnage-Dona, R. (2020). Quantitative assessment of the impact of viral state on the rate of tumour progression in patients receiving sorafenib for advanced hepatocellular carcinoma. Poster session presented at the meeting of Unknown Conference. Retrieved from https://www.webofscience.com/
The prognostic and diagnostic significance of the neutrophil to lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study
Johnson, P., Dhanaraj, S., Ma, Y. T., Bonnett, L., & Berhane, S. (2020). The prognostic and diagnostic significance of the neutrophil to lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study. Journal of Hepatology, 73, S388. doi:10.1016/s0168-8278(20)31266-6
Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach
Han, G., Berhane, S., Toyoda, H., Bettinger, D., Elshaarawy, O., Chan, A. W. H., . . . Johnson, P. J. (2020). Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response-Based Approach. Hepatology (Baltimore, Md.), 72(01), 198-212. doi:10.1002/hep.31022
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Kudo, M., Ueshima, K., Ikeda, M., Torimura, T., Tanabe, N., Aikata, H., . . . TACTICS study group. (2020). Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.. Gut, 69(8), 1492-1501. doi:10.1136/gutjnl-2019-318934
Impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis: a prospective serial follow-up MRI study
Kumada, T., Toyoda, H., Yasuda, S., Tada, T., Ogawa, S., Takeshima, K., . . . Johnson, P. J. (2020). Impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis: a prospective serial follow-up MRI study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 52(2), 359-370. doi:10.1111/apt.15825
Validation and refinement of PROSASH model using the neutrophil‐to‐lymphocyte ratio in patients with HCC receiving sorafenib
Casadei‐Gardini, A., Cabibbo, G., Dadduzio, V., Orsi, G., Vukotic, R., Rizzato, M. D., . . . Cucchetti, A. (2020). Validation and refinement of PROSASH model using the neutrophil‐to‐lymphocyte ratio in patients with HCC receiving sorafenib. Liver Cancer International, 1(1), 6-11. doi:10.1002/lci2.12
Serum Levels of Alpha Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma
Hughes, D. M., Berhane, S., Emily de Groot, C. A., Toyoda, H., Tada, T., Kumada, T., . . . Johnson, P. (2020). Serum Levels of Alpha Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2020.04.084
Response to: Prognostication of HCC patients under sorafenib is not always possible
Labeur, T. A., Berhane, S., & Johnson, P. J. (2020). Response to: Prognostication of HCC patients under sorafenib is not always possible. LIVER INTERNATIONAL, 40(5), 1243-1244. doi:10.1111/liv.14335
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Best, J., Bechmann, L. P., Sowa, J. -P., Sydor, S., Dechene, A., Pflanz, K., . . . Canbay, A. (2020). GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 18(3), 728-+. doi:10.1016/j.cgh.2019.11.012
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
Labeur, T. A., Berhane, S., Edeline, J., Blanc, J. -F., Bettinger, D., Meyer, T., . . . Johnson, P. J. (2020). Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib. LIVER INTERNATIONAL, 40(1), 215-228. doi:10.1111/liv.14270
2019
The chances of hepatic resection curing hepatocellular carcinoma.
Cucchetti, A., Zhong, J., Berhane, S., Toyoda, H., Shi, K., Tada, T., . . . Johnson, P. J. (2019). The chances of hepatic resection curing hepatocellular carcinoma.. Journal of hepatology. doi:10.1016/j.jhep.2019.11.016
Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials
Cabibbo, G., Cucchetti, A., Cammà, C., Casadei-Gardini, A., Celsa, C., Emanuele Maria Rizzo, G., . . . Ercolani, G. (2019). Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials. Future Oncology, 15(29), 3411-3422. doi:10.2217/fon-2019-0287
Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of Decompensation
Guha, I. N., Harris, R., Berhane, S., Dillon, A., Coffey, L., James, M. W., . . . Johnson, P. J. (2019). Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of Decompensation. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17(11), 2330-+. doi:10.1016/j.cgh.2019.01.042
The Epidemiology of Hepatocellular Carcinoma
Johnson, P. (2019). The Epidemiology of Hepatocellular Carcinoma. In Liver Cancers (pp. 3-11). Springer International Publishing. doi:10.1007/978-3-319-92216-4_1
A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma
Amoros, R., King, R., Toyoda, H., Kumada, T., Johnson, P. J., & Bird, T. G. (2019). A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma. Metron, 77(2), 67-86. doi:10.1007/s40300-019-00151-8
Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment
Berhane, S., Fox, R., Garcia-Finana, M., Cucchetti, A., & Johnson, P. (2019). Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment. British Journal of Cancer, 121, 117-124. doi:10.1038/s41416-019-0488-4
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study
Ueshima, K., Nishida, N., Hagiwara, S., Aoki, T., Minami, T., Chishina, H., . . . Kudo, M. (2019). Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study. CANCERS, 11(7). doi:10.3390/cancers11070952
Multicentre validation of a clinical prognostic score integrating the systemic inflammatory response to the host for patients treated with curative-intent for colorectal liver metastases: The Liverpool score
Dupre, A., Berhane, S., Chan, A. W. H., Rivoire, M., Chong, C. C. N., Lai, P. B. S., . . . Johnson, P. J. (2019). Multicentre validation of a clinical prognostic score integrating the systemic inflammatory response to the host for patients treated with curative-intent for colorectal liver metastases: The Liverpool score. EJSO, 45(6), 999-1004. doi:10.1016/j.ejso.2019.02.022
Trial endpoints for systemic therapy in patients with hepatocellular carcinoma
Meyer, T., & Johnson, P. (2019). Trial endpoints for systemic therapy in patients with hepatocellular carcinoma. JOURNAL OF HEPATOLOGY, 70(6), 1060-1061. doi:10.1016/j.jhep.2019.03.001
Impact of primary cancer features on behaviour of colorectal liver metastases and survival after hepatectomy
Cucchetti, A., Russolillo, N., Johnson, P., Tarchi, P., Ferrero, A., Cucchi, M., . . . Ercolani, G. (2019). Impact of primary cancer features on behaviour of colorectal liver metastases and survival after hepatectomy. BJS OPEN, 3(2), 186-194. doi:10.1002/bjs5.100
Reply to: Correspondence concerning "Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection"
Chan, A. W. H., Berhane, S., Cucchetti, A., & Johnson, P. J. (2019). Reply to: Correspondence concerning "Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection". JOURNAL OF HEPATOLOGY, 70(3), 573-574. doi:10.1016/j.jhep.2018.11.026
The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study
Toyoda, H., Kumada, T., Tada, T., Mizuno, K., Sone, Y., Akita, T., . . . Johnson, P. J. (2019). The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study. Liver International, 39(3), 448-454. doi:10.1111/liv.13987
Very Early Diagnosis of Hepatocellular Carcinoma: Serological Approaches
Johnson, P. J. (2019). Very Early Diagnosis of Hepatocellular Carcinoma: Serological Approaches. In JOURNAL OF PATHOLOGY Vol. 248 (pp. S3). Retrieved from https://www.webofscience.com/
2018
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.
Chan, A. W. H., Zhong, J., Berhane, S., Toyoda, H., Cucchetti, A., Shi, K., . . . Johnson, P. J. (2018). Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.. Journal of hepatology, 69(6), 1284-1293. doi:10.1016/j.jhep.2018.08.027
Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma
Pinna, A. D., Yang, T., Mazzaferro, V., De Carlis, L., Zhou, J., Roayaie, S., . . . Cucchetti,, A. (2018). Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma. Annals of Surgery, 268(5), 868-875. Retrieved from https://journals.lww.com/
A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection
Cai, B. -B., Shi, K. -Q., Li, P., Chen, B. -C., Shi, L., Johnson, P. J., . . . Zhou, M. -T. (2018). A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection. CLINICA CHIMICA ACTA, 485, 187-194. doi:10.1016/j.cca.2018.06.020
Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma
Chong, C. C. -N., Chan, A. W. -H., Wong, J., Chu, C. -M., Chan, S. L., Lee, K. -F., . . . Lai, P. B. -S. (2018). Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 16(3), 163-170. doi:10.1016/j.surge.2017.07.003
Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection
Chong, C. C. N., Lee, K. -F., Chu, C. -M., Chan, A. W. H., Wong, J., Chan, S. L., . . . Lai, P. B. S. (2018). Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection. HPB, 20(6), 546-554. doi:10.1016/j.hpb.2017.12.001
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial
Kudo, M., Ueshima, K., Yokosuka, O., Ogasawara, S., Obi, S., Izumi, N., . . . SILIUS Study Group. (2018). Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 3(6), 424-432. doi:10.1016/S2468-1253(18)30078-5
A statistical model for survival risk prediction in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment
Berhane, S., Fox, R., Chan, S. L., Yau, T., & Johnson, P. (2018). A statistical model for survival risk prediction in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment. In JOURNAL OF HEPATOLOGY Vol. 68 (pp. S197-S198). doi:10.1016/S0168-8278(18)30607-X
Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection
Toyoda, H., Berhane, S., de Groot, E., Tada, T., Kumada, T., Irving, W., & Johnson, P. (2018). Impact of direct-acting antiviral agents on liver function in patients with chronic hepatitis C virus infection. In JOURNAL OF HEPATOLOGY Vol. 68 (pp. S530). doi:10.1016/S0168-8278(18)31312-6
Serological diagnosis of early HCC in NASH: A German multicenter study
Best, J., Bechmann, L., Dechene, A., Pflanz, K., Bedreli, S., Schotten, C., . . . Canbay, A. (2018). Serological diagnosis of early HCC in NASH: A German multicenter study. In JOURNAL OF HEPATOLOGY Vol. 68 (pp. S421-S422). doi:10.1016/S0168-8278(18)31083-3
Predictors of sorafenib benefit in patients with hepatocellular carcinoma
Jackson, R., Psarelli, E., Berhane, S., & Johnson, P. J. (2018). Predictors of sorafenib benefit in patients with hepatocellular carcinoma. Journal of Hepatology, 68(3), 619-620. doi:10.1016/j.jhep.2017.09.028
2017
Risk estimation for biliary tract cancer: Development and validation of a prognostic score
Schweitzer, N., Fischer, M., Kirstein, M. M., Berhane, S., Kottas, M., Sinn, M., . . . Vogel, A. (2017). Risk estimation for biliary tract cancer: Development and validation of a prognostic score. LIVER INTERNATIONAL, 37(12), 1852-1860. doi:10.1111/liv.13517
Reply to 'Comment on 'Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion''
Waked, I., & Johnson, P. J. (2017). Reply to 'Comment on 'Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion''. BRITISH JOURNAL OF CANCER, 117(10). doi:10.1038/bjc.2017.241
Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey.
Toyoda, H., Tada, T., Johnson, P. J., Izumi, N., Kadoya, M., Kaneko, S., . . . Kudo, M. (2017). Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey. JOURNAL OF GASTROENTEROLOGY, 52(10), 1112-1121. doi:10.1007/s00535-017-1321-6
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Meyer, T., Fox, R., Ma, Y. T., Ross, P. J., James, M. W., Sturgess, R., . . . Palmer, D. H. (2017). Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2(8), 565-575. doi:10.1016/S2468-1253(17)30156-5
Assessment of Liver Function: Focus on the ALBI Score
Johnson, P. J., Khan, H., & Berhane, S. (2017). Assessment of Liver Function: Focus on the ALBI Score. In Radiation Therapy for Liver Tumors (pp. 31-38). Springer International Publishing. doi:10.1007/978-3-319-54531-8_3
Reply to N. Personeni et al
Jackson, R., Psarelli, E., & Johnson, P. J. (2017). Reply to N. Personeni et al. Journal of Clinical Oncology, 35(19), 2214. doi:10.1200/JCO.2017.72.9293
The BALAD-2 and GALAD Biomarker Models for Hepatocellular Carcinoma
Johnson, P. J. (2017). The BALAD-2 and GALAD Biomarker Models for Hepatocellular Carcinoma. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 15(6), 452-454. Retrieved from https://www.webofscience.com/
Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit.
King, J., Palmer, D. H., Johnson, P., Ross, P., Hubner, R. A., Sumpter, K., . . . Meyer, T. (2017). Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK Audit.. Clinical oncology (Royal College of Radiologists (Great Britain)), 29(4), 256-262. doi:10.1016/j.clon.2016.11.012
The BALAD-2 and GALAD Biomarker Models for Hepatocellular Carcinoma.
Johnson, P. J. (2017). The BALAD-2 and GALAD Biomarker Models for Hepatocellular Carcinoma.. Gastroenterology & hepatology, 13(4), 231-233.
Ultrasound surveillance for hepatocellular carcinoma: service evaluation of a radiology-led recall system in a tertiary-referral centre for liver diseases in the UK
Farrell, C., Halpen, A., Cross, T. J. S., Richardson, P. D., Johnson, P., & Joekes, E. C. (2017). Ultrasound surveillance for hepatocellular carcinoma: service evaluation of a radiology-led recall system in a tertiary-referral centre for liver diseases in the UK. CLINICAL RADIOLOGY, 72(4). doi:10.1016/j.crad.2016.10.019
Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials
Jackson, R., Psarelli, E. E., Berhane, S., Khan, H., & Johnson, P. J. (2017). Impact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials. Journal of Clinical Oncology, 35(6), 622-628. doi:10.1200/JCO.2016.69.5197
Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance
Johnson, P., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M., Fox, R., . . . Kumada, T. (2017). Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance. British Journal of Cancer, 116, 441-447. doi:10.1038/bjc.2016.422
Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion
Waked, I., Berhane, S., Toyoda, H., Chan, S. L., Stern, N., Palmer, D., . . . Johnson, P. J. (2017). Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion. BRITISH JOURNAL OF CANCER, 116(4), 448-454. doi:10.1038/bjc.2016.423
Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: A meta-analysis of randomised phase III trials
Johnson, P. J., Jackson, R., Berhane, S., & Psarelli, E. (2017). Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: A meta-analysis of randomised phase III trials. Journal of Clinical Oncology. doi:10.1200/JCO.2016.69.5197
Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma
Chan, A. W. H., Chong, C. C. N., Mo, F. K. F., Wong, J., Yeo, W., Johnson, P. J., . . . Chan, S. L. (2017). Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32(1), 221-228. doi:10.1111/jgh.13457
Liver function as measured by albumin-bilirubin score within decompensated patients receiving direct acting antiviral therapy within the Expanded Access Programme
Walker, A. J., Johnson, P. J., & Irving, W. L. (2017). Liver function as measured by albumin-bilirubin score within decompensated patients receiving direct acting antiviral therapy within the Expanded Access Programme. In JOURNAL OF HEPATOLOGY Vol. 66 (pp. S746-S747). doi:10.1016/S0168-8278(17)31986-4
Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study
Broadhurst, P., Toyoda, H., Kumada, T., Schweitzer, N., Vogel, A., Benckert, J., . . . Johnson, P. (2017). Prognostic impact of serum alpha-fetoprotein in patients with hepatocellular carcinoma: an international collaborative study. In JOURNAL OF HEPATOLOGY Vol. 66 (pp. S620-S621). doi:10.1016/S0168-8278(17)31684-7
Serial changes in serum biomarkers (GALAD model) prior to detection of HCC by ultrasound surveillance; application of statistical process control methodology
Berhane, S., Johnson, P. J., Tada, T., Toyoda, H., Fox, R., Cox, T., & Kumada, T. (2017). Serial changes in serum biomarkers (GALAD model) prior to detection of HCC by ultrasound surveillance; application of statistical process control methodology. In JOURNAL OF HEPATOLOGY Vol. 66 (pp. S628). doi:10.1016/S0168-8278(17)31703-8
Serum biomarker ('GALAD') response after resection of hepatocellular carcinoma: impact of tumour recurrence
Johnson, P. J., Berhane, S., Tada, T., Toyoda, H., & Kumada, T. (2017). Serum biomarker ('GALAD') response after resection of hepatocellular carcinoma: impact of tumour recurrence. In JOURNAL OF HEPATOLOGY Vol. 66 (pp. S621). doi:10.1016/S0168-8278(17)31685-9
2016
Protein Biomarkers in the Management of Hepatocellular Carcinoma: Novel Combinatory Approaches
Johnson, P., & Berhane, S. (2016). Protein Biomarkers in the Management of Hepatocellular Carcinoma: Novel Combinatory Approaches. In HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND TREATMENT, 3RD EDITION (pp. 331-338). doi:10.1007/978-3-319-34214-6_21
A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma
Edeline, J., Blanc, J. -F., Johnson, P., Campillo-Gimenez, B., Ross, P., Ma, Y. T., . . . Meyer, T. (2016). A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 36(12), 1821-1828. doi:10.1111/liv.13170
Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma
Chan, A. W. H., Chong, C. C. N., Mo, F. K. F., Wong, J., Yeo, W., Johnson, P. J., . . . Chan, S. L. (2016). Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31(10), 1766-1772. doi:10.1111/jgh.13339
The GALAD serological model may permit earlier diagnosis of hepatocellular carcinoma in a screened cirrhotic population: a re-analysis of a prospective trial
Johnson, P. J., de Groot, E., Yamada, H., & Berhane, S. (2016). The GALAD serological model may permit earlier diagnosis of hepatocellular carcinoma in a screened cirrhotic population: a re-analysis of a prospective trial. In HEPATOLOGY Vol. 64 (pp. 644A). Retrieved from https://www.webofscience.com/
Reply to: Comment on: 'Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
Johnson, P., Lai, P. B. S., & Toyoda, H. (2016). Reply to: Comment on: 'Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'. BRITISH JOURNAL OF CANCER, 115(5), E6. doi:10.1038/bjc.2016.197
Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma
Chan, A. W. H., Kumada, T., Toyoda, H., Tada, T., Chong, C. C. N., Mo, F. K. F., . . . Chan, S. L. (2016). Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31(7), 1300-1306. doi:10.1111/jgh.13291
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Berhane, S., Toyoda, H., Tada, T., Kumada, T., Kagebayashi, C., Satomura, S., . . . Johnson, P. (2016). Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 14(6), 875-+. doi:10.1016/j.cgh.2015.12.042
TACE 2: A randomized placebo-controlled, double blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC) Background
Meyer, T., Fox, R., Ma, Y. T., Ross, P. J., James, M., Strugess, R., . . . Palmer, D. H. (2016). TACE 2: A randomized placebo-controlled, double blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC) Background. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34. doi:10.1200/JCO.2016.34.15_suppl.4018
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade
Toyoda, H., Lai, P. B. S., O'Beirne, J., Chong, C. C., Berhane, S., Reeves, H., . . . Johnson, P. J. (2016). Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. BRITISH JOURNAL OF CANCER, 114(7), 744-750. doi:10.1038/bjc.2016.33
IDENTIFICATION OF ADVANCED FIBROSIS IN HEPATITIS C PATIENTS FOLLOWING SUSTAINED VIROLOGIC RESPONSE: A NEW PREDICTIVE MODEL
Berhane, S., Tachi, Y., Tada, T., Johnson, P., Kumada, T., & Toyoda, H. (2016). IDENTIFICATION OF ADVANCED FIBROSIS IN HEPATITIS C PATIENTS FOLLOWING SUSTAINED VIROLOGIC RESPONSE: A NEW PREDICTIVE MODEL. In JOURNAL OF HEPATOLOGY Vol. 64 (pp. S738-S739). doi:10.1016/S0168-8278(16)01435-5
IMPACT OF AETIOLOGY ON SURVIVAL AFTER SORAFENIB TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS OF THREE LARGE RANDOMISED TRIALS
Johnson, P. J., Jackson, R., Psarelli, E. -E., Khan, H., & Berhane, S. (2016). IMPACT OF AETIOLOGY ON SURVIVAL AFTER SORAFENIB TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS OF THREE LARGE RANDOMISED TRIALS. JOURNAL OF HEPATOLOGY, 64, S222-S223. doi:10.1016/S0168-8278(16)00197-5
LONG-TERM IMPACT OF RESPONSE TO INTERFERON-BASED THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS IN RELATION TO LIVER FUNCTION, SURVIVAL AND CAUSE OF DEATH
Johnson, P., de Groot, E., Berhane, S., Tada, T., Kumada, T., & Toyoda, H. (2016). LONG-TERM IMPACT OF RESPONSE TO INTERFERON-BASED THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS IN RELATION TO LIVER FUNCTION, SURVIVAL AND CAUSE OF DEATH. In JOURNAL OF HEPATOLOGY Vol. 64 (pp. S811-S812). doi:10.1016/S0168-8278(16)01585-3
Long-term impact of response to interferon-based therapy in patients with chronic HCV in relation to liver function, survival and cause of death
Johnson, P. J., de Groot, E., Berhane, S., Tada, T., Kumada, T., & Toyoda, H. (2016). Long-term impact of response to interferon-based therapy in patients with chronic HCV in relation to liver function, survival and cause of death. In HEPATOLOGY Vol. 64 (pp. 444A). Retrieved from https://www.webofscience.com/
2015
Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma
Chan, S. L., Mo, F., Johnson, P., Li, L., Tang, N., Loong, H., . . . Yeo, W. (2015). Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30(10), 1529-1535. doi:10.1111/jgh.13005
Evaluating the role of treatment-related toxicities in the challenges facing targeted therapies for advanced hepatocellular carcinoma
Palmer, D. H., & Johnson, P. J. (2015). Evaluating the role of treatment-related toxicities in the challenges facing targeted therapies for advanced hepatocellular carcinoma. CANCER AND METASTASIS REVIEWS, 34(3), 497-509. doi:10.1007/s10555-015-9580-2
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.
Park, J. -W., Chen, M., Colombo, M., Roberts, L. R., Schwartz, M., Chen, P. -J., . . . Sherman, M. (2015). Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.. Liver international : official journal of the International Association for the Study of the Liver, 35(9), 2155-2166. doi:10.1111/liv.12818
Impact of Cytomegalovirus on Long-term Mortality and Cancer Risk After Organ Transplantation
Desai, R., Collett, D., Watson, C. J. E., Johnson, P. J., Moss, P., & Neuberger, J. (2015). Impact of Cytomegalovirus on Long-term Mortality and Cancer Risk After Organ Transplantation. TRANSPLANTATION, 99(9), 1989-1994. doi:10.1097/TP.0000000000000641
Integration of Albumin-Bilirubin (ALBI) score into current tumour staging system for hepatocellular carcinoma (HCC)
Chan, S. L., To, K. F., Mo, F., Chong, C. C. N., Yeo, W., Johnson, P., . . . Chan, A. W. H. (2015). Integration of Albumin-Bilirubin (ALBI) score into current tumour staging system for hepatocellular carcinoma (HCC). In EUROPEAN JOURNAL OF CANCER Vol. 51 (pp. S414). doi:10.1016/S0959-8049(16)31160-1
The Role of hepatic resection in the treatment of hepatocellular cancer
Roayaie, S., Jibara, G., Tabrizian, P., Park, J. -W., Yang, J., Yan, L., . . . Sherman, M. (2015). The Role of hepatic resection in the treatment of hepatocellular cancer. Hepatology, 62(2), 440-451. doi:10.1002/hep.27745
Optimisation of pharmacy content in clinical cancer research protocols: Experience of the United Kingdom Chemotherapy and Pharmacy Advisory Service
Debruyne, P. R., Johnson, P. J., Pottel, L., Daniels, S., Greer, R., Hodgkinson, E., . . . Harvey, S. (2015). Optimisation of pharmacy content in clinical cancer research protocols: Experience of the United Kingdom Chemotherapy and Pharmacy Advisory Service. CLINICAL TRIALS, 12(3), 257-264. doi:10.1177/1740774515569610
ALBI SCORE PREDICTS SURVIVAL IN PATIENTS WITH BCLC 0/A STAGE HEPATOCELLULAR CARCINOMA (HCC) INDEPENDENTLY OF CHILD PUGH (CP) SCORE AND TREATMENT ALLOCATION
Onali, S., Marshall, A., Sharma, D., O'Donoghue, P., Dannhorn, E., Johnson, P., & O'Beirne, J. (2015). ALBI SCORE PREDICTS SURVIVAL IN PATIENTS WITH BCLC 0/A STAGE HEPATOCELLULAR CARCINOMA (HCC) INDEPENDENTLY OF CHILD PUGH (CP) SCORE AND TREATMENT ALLOCATION. In GUT Vol. 64 (pp. A459-A460). doi:10.1136/gutjnl-2015-309861.1006
ALBI SCORE PREDICTS SURVIVAL INDEPENDENTLY OF HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND INDOCYANINE GREEN (ICG) CLEARANCE IN HCC PATIENTS UNDERGOING RESECTION
Onali, S., Marshall, A., Sharma, D., O'Donoghue, P., Dannhorn, E., Johnson, P., & O'Beirne, J. (2015). ALBI SCORE PREDICTS SURVIVAL INDEPENDENTLY OF HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND INDOCYANINE GREEN (ICG) CLEARANCE IN HCC PATIENTS UNDERGOING RESECTION. In GUT Vol. 64 (pp. A460-A461). doi:10.1136/gutjnl-2015-309861.1008
URINARY VOLATILE ORGANIC COMPOUNDS AS A BIOMARKER FOR HEPATOCELLULAR CARCINOMA (HCC)
Bond, A., Aggio, R., Johnson, P., Berhane, S., & Probert, C. (2015). URINARY VOLATILE ORGANIC COMPOUNDS AS A BIOMARKER FOR HEPATOCELLULAR CARCINOMA (HCC). In GUT Vol. 64 (pp. A462). doi:10.1136/gutjnl-2015-309861.1011
THE 'GALAD SCORE' FOR SEROLOGICAL DETECTION OF HEPATOCELLULAR CARCINOMA: INTERNATIONAL VALIDATION AND ASSESSMENT OF THE INFLUENCE OF TUMOUR SIZE AND AETIOLOGY ON MODEL UTILITY
Berhane, S., Toyoda, H., Tada, T., Kumada, T., Kagebayashi, C., Satomura, S., . . . Johnson, P. (2015). THE 'GALAD SCORE' FOR SEROLOGICAL DETECTION OF HEPATOCELLULAR CARCINOMA: INTERNATIONAL VALIDATION AND ASSESSMENT OF THE INFLUENCE OF TUMOUR SIZE AND AETIOLOGY ON MODEL UTILITY. In JOURNAL OF HEPATOLOGY Vol. 62 (pp. S434). doi:10.1016/S0168-8278(15)30546-8
Are the current EASL/AASLD guidelines for resection of hepatocellular carcinoma optimal? Analysis of the BRIDGE study
Johnson, P. J., Roayaie, S., Jibara, G., Tabrizian, P., Park, J. -W., Yang, J., . . . Sherman, M. (2015). Are the current EASL/AASLD guidelines for resection of hepatocellular carcinoma optimal? Analysis of the BRIDGE study. Hepatology. doi:10.1002/hep.27745
Assessment of liver function in patients with hepatocellular caicnoma: a new evidence-based approach - The ALBI Grade
Johnson, P., & Berhane, S. (2015). Assessment of liver function in patients with hepatocellular caicnoma: a new evidence-based approach - The ALBI Grade. Journal of Clinical Oncology, 33(6), 550-558. doi:10.1200/JCO.2014.57.9151
PALBI-An Objective Score Based on Platelets, Albumin & Bilirubin Stratifies HCC Patients Undergoing Resection & Ablation Better than Child's Classification
Roayaie, S., Jibara, G., Berhane, S., Tabrizian, P., Park, J. -W., Yang, J., . . . Johnson, P. (2015). PALBI-An Objective Score Based on Platelets, Albumin & Bilirubin Stratifies HCC Patients Undergoing Resection & Ablation Better than Child's Classification. In HEPATOLOGY Vol. 62 (pp. 631A-632A). Retrieved from https://www.webofscience.com/
Survival After Intra-Arterial Treatment for Hepatocellular Carcinoma: Impact of Liver Dysfunction and Development of a Predictive Statistical Model: an International Collaborative Project
Waked, I., Berhane, S., Chan, S. L., Gomaa, A., Inarrairaegui, M., Alkhatib, Z., . . . Johnson, P. (2015). Survival After Intra-Arterial Treatment for Hepatocellular Carcinoma: Impact of Liver Dysfunction and Development of a Predictive Statistical Model: an International Collaborative Project. In HEPATOLOGY Vol. 62 (pp. 384A-385A). Retrieved from https://www.webofscience.com/
2014
315. MicroRNA-122 as a serum biomarker for hepatocellular carcinoma
McWhirter, D., Malik, H. Z., Fenwick, S. W., Poston, G. J., Kitteringham, N. R., Goldring, C. E., . . . Palmer, D. (2014). 315. MicroRNA-122 as a serum biomarker for hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO), 40(11), S125. doi:10.1016/j.ejso.2014.08.306
Hepatocellular carcinoma
Palmer, D. H., & Johnson, P. J. (2014). Hepatocellular carcinoma. In Treatment of Cancer (pp. 201-212). CRC Press. doi:10.1201/b17751-9
The United Kingdom (Uk) National Cancer Research Network (Ncrn) Chemotherapy and Pharmacy Advisory Service (Cpas): Service Development and Quality Control Experience of Pharmacy Aspects in Clinical Research Protocols
Debruyne, P. R., Johnson, P., Pottel, L., Daniels, S., Greer, R., Hodgkinson, E., . . . Harvey, S. (2014). The United Kingdom (Uk) National Cancer Research Network (Ncrn) Chemotherapy and Pharmacy Advisory Service (Cpas): Service Development and Quality Control Experience of Pharmacy Aspects in Clinical Research Protocols. Annals of Oncology, 25, iv491. doi:10.1093/annonc/mdu353.21
Assessment of liver dysfunction in hepatocellular carcinoma (HCC): An international collaborative study.
Johnson, P. J., Berhane, S., Kagebayashi, C., Satomura, S., Teng, M. J., Skowronska, A., . . . Kumada, T. (2014). Assessment of liver dysfunction in hepatocellular carcinoma (HCC): An international collaborative study.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 32. doi:10.1200/jco.2014.32.15_suppl.4094
Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry
Desai, R., Collett, D., Watson, C. J. E., Johnson, P., Evans, T., & Neuberger, J. (2014). Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry. British Journal of Surgery, 101(7), 768-774. doi:10.1002/bjs.9460
Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma
Teng, M., Pirrie, S., Ward, D. G., Assi, L. K., Hughes, R. G., Stocken, D., & Johnson, P. J. (2014). Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma. BRITISH JOURNAL OF CANCER, 110(9), 2277-2282. doi:10.1038/bjc.2014.121
Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model
Fox, R., Berhane, S., Teng, M., Cox, T., Tada, T., Toyoda, H., . . . Johnson, P. J. (2014). Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model. British Journal of Cancer, 110(8), 2090-2098. doi:10.1038/bjc.2014.130
AN INTERNATIONAL COLLABORATIVE STUDY ASSESSING THE ROLE OF AETIOLOGY AND STAGE IN SURVIVAL IN HCC - IMPLICATIONS FOR SCREENING
Johnson, P., Berhane, S., Satomura, S., Tada, T., Kumada, T., Teng, M., . . . Toyoda, H. (2014). AN INTERNATIONAL COLLABORATIVE STUDY ASSESSING THE ROLE OF AETIOLOGY AND STAGE IN SURVIVAL IN HCC - IMPLICATIONS FOR SCREENING. In JOURNAL OF HEPATOLOGY Vol. 60 (pp. S45-S46). doi:10.1016/S0168-8278(14)60112-4
ASSESSMENT OF PROGNOSIS IN HEPATOCELLULAR CARCINOMA USING A BIOMARKER BASED APPROACH: VALIDATION AND EXTENSION OF THE BALAD MODEL
Fox, R., Berhane, S., Teng, M., Cox, T., Tada, T., Toyoda, H., . . . Johnson, P. (2014). ASSESSMENT OF PROGNOSIS IN HEPATOCELLULAR CARCINOMA USING A BIOMARKER BASED APPROACH: VALIDATION AND EXTENSION OF THE BALAD MODEL. In JOURNAL OF HEPATOLOGY Vol. 60 (pp. S254). doi:10.1016/S0168-8278(14)60716-9
Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?
Llovet, J. M., & Johnson, P. J. (2014). Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?. JOURNAL OF CLINICAL ONCOLOGY, 32(9), 968-969. doi:10.1200/JCO.2013.53.8199
Reply to X. Qi et al.
Llovet, J. M., & Johnson, P. J. (2014). Reply to X. Qi et al.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(9), 968-969. doi:10.1200/jco.2013.54.3033
Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma.
Qi, Y. -J., Ward, D. G., Pang, C., Wang, Q. -M., Wei, W., Ma, J., . . . Johnson, P. J. (2014). Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma.. Proteomics, 14(2-3), 186-195. doi:10.1002/pmic.201300226
Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers
Malottki, K., Biswas, M., Deeks, J. J., Riley, R. D., Craddock, C., Johnson, P., & Billingham, L. (2014). Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers. BMJ OPEN, 4(1). doi:10.1136/bmjopen-2013-004188
A joint United Kingdom (UK) and Hong Kong (HK) study to determine prognostic factors for hepatocellular carcinoma (HCC) undergoing curative and palliative treatment
Chan, S. L., Johnson, P. J., Mo, F., Berhane, S., Ma, B., Teng, M., . . . Yeo, W. (2014). A joint United Kingdom (UK) and Hong Kong (HK) study to determine prognostic factors for hepatocellular carcinoma (HCC) undergoing curative and palliative treatment. In JOURNAL OF CLINICAL ONCOLOGY Vol. 32. doi:10.1200/jco.2014.32.3_suppl.181
International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study.
Chan, S. L., Johnson, P. J., Mo, F., Berhane, S., Teng, M., Chan, A. W. H., . . . Yeo, W. (2014). International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study.. Chinese journal of cancer, 33(10), 481-491. doi:10.5732/cjc.014.10133
Performance of serum a-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass
Chan, S. L., Mo, F., Johnson, P. J., Siu, D. Y. W., Chan, M. H. M., Lau, W. Y., . . . Yu, S. C. H. (2014). Performance of serum a-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass. HPB, 16(4), 366-372. doi:10.1111/hpb.12146
The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers
Johnson, P. J., Pirrie, S. J., Cox, T. F., Berhane, S., Teng, M. J., Palmer, D. H., . . . Satomura, S. (2014). The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers. Cancer Epidemiology, Biomarkers and Prevention, 23(1), 144-153. doi:10.1158/1055-9965.EPI-13-0870
The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers.
Johnson, P. J., Pirrie, S. J., Cox, T. F., Berhane, S., Teng, M., Palmer, D., . . . Satomura, S. (2014). The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers.. Cancer Epidemiology Biomarkers Preview.
2013
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study.
Johnson, P. J., Qin, S., Park, J. -W., Poon, R. T. P., Raoul, J. -L., Philip, P. A., . . . Cheng, A. -L. (2013). Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(28), 3517-3524. doi:10.1200/jco.2012.48.4410
Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom
Palmer, D. H., Hussain, S. A., Smith, A. J., Hargreaves, S., Ma, Y. T., Hull, D., . . . Ross, P. J. (2013). Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom. BRITISH JOURNAL OF CANCER, 109(4), 888-890. doi:10.1038/bjc.2013.410
Sorafenib for Advanced Hepatocellular Carcinoma (HCC): Impact of rationing in the United Kingdom
Palmer, D. H., Hussain, S. A., Smith, A. J., Hull, D., Johnson, P. J., & Ross, P. (2013). Sorafenib for Advanced Hepatocellular Carcinoma (HCC): Impact of rationing in the United Kingdom. British Journal of cancer, 109(4), 888-890. doi:10.1038/bjc.2013.410
Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
Colombo, M., Raoul, J. -L., Lencioni, R., Galle, P. R., Zucman-Rossi, J., Bañares, R., . . . Johnson, P. (2013). Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.. European journal of gastroenterology & hepatology, 25(6), 639-651. doi:10.1097/meg.0b013e32835e33bb
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma.
Shimwell, N. J., Bryan, R. T., Wei, W., James, N. D., Cheng, K. K., Zeegers, M. P., . . . Ward, D. G. (2013). Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma.. British journal of cancer, 108(9), 1854-1861. doi:10.1038/bjc.2013.157
MALDI profiles of proteins and lipids for the rapid characterisation of upper GI-tract cancers.
Singhal, R., Carrigan, J. B., Wei, W., Taniere, P., Hejmadi, R. K., Forde, C., . . . Ward, D. G. (2013). MALDI profiles of proteins and lipids for the rapid characterisation of upper GI-tract cancers.. Journal of proteomics, 80, 207-215. doi:10.1016/j.jprot.2013.01.016
Production of nanoparticles-in-microparticles by a double emulsion method: a comprehensive study.
Lee, Y. -S., Johnson, P. J., Robbins, P. T., & Bridson, R. H. (2013). Production of nanoparticles-in-microparticles by a double emulsion method: a comprehensive study.. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 83(2), 168-173. doi:10.1016/j.ejpb.2012.10.016
A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.
Kadalayil, L., Benini, R., Pallan, L., O'Beirne, J., Marelli, L., Yu, D., . . . Meyer, T. (2013). A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.. Annals of oncology : official journal of the European Society for Medical Oncology, 24(10), 2565-2570. doi:10.1093/annonc/mdt247
How do mechanisms of hepatocarcinogenesis (HBV, HCV, and NASH) affect our understanding and approach to HCC?
Johnson, P. J. (2013). How do mechanisms of hepatocarcinogenesis (HBV, HCV, and NASH) affect our understanding and approach to HCC?. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. doi:10.14694/edbook_am.2013.33.e132
2012
Cancer transmission from organ donors-unavoidable but low risk.
Desai, R., Collett, D., Watson, C. J., Johnson, P., Evans, T., & Neuberger, J. (2012). Cancer transmission from organ donors-unavoidable but low risk.. Transplantation, 94(12), 1200-1207. doi:10.1097/tp.0b013e318272df41
Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas.
Shimwell, N. J., Ward, D. G., Mohri, Y., Mohri, T., Pallan, L., Teng, M., . . . Johnson, P. J. (2012). Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas.. British journal of cancer, 107(9), 1595-1601. doi:10.1038/bjc.2012.405
Encapsulation of Liposomes within pH Responsive Microspheres for Oral Colonic Drug Delivery.
Barea, M. J., Jenkins, M. J., Lee, Y. S., Johnson, P., & Bridson, R. H. (2012). Encapsulation of Liposomes within pH Responsive Microspheres for Oral Colonic Drug Delivery.. International journal of biomaterials, 2012, 458712. doi:10.1155/2012/458712
Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: an Asian perspective.
Chan, S. L., & Johnson, P. (2012). Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: an Asian perspective.. Asia-Pacific journal of clinical oncology, 8(2), 111-114. doi:10.1111/j.1743-7563.2012.01551.x
719 OBSERVATIONS OF HEPATOCELLULAR CARCINOMA (HCC) MANAGEMENT PATTERNS FROM THE GLOBAL HCC BRIDGE STUDY: SECOND INTERIM ANALYSIS OF THE EUROPEAN (EU) COHORT
Izzo, F., Colombo, M., Leroy, V., Blanc, J. -F., Johnson, P., Fenwick, S., . . . Orsini, L. (2012). 719 OBSERVATIONS OF HEPATOCELLULAR CARCINOMA (HCC) MANAGEMENT PATTERNS FROM THE GLOBAL HCC BRIDGE STUDY: SECOND INTERIM ANALYSIS OF THE EUROPEAN (EU) COHORT. Journal of Hepatology, 56, S284. doi:10.1016/s0168-8278(12)60732-6
Sample size calculations for designing clinical proteomic profiling studies using mass spectrometry.
Nyangoma, S. O., Collins, S. I., Altman, D. G., Johnson, P., & Billingham, L. J. (2012). Sample size calculations for designing clinical proteomic profiling studies using mass spectrometry.. Statistical applications in genetics and molecular biology, 11(3), Article-2. doi:10.1515/1544-6115.1686
Gemcitabine chemotherapy until symptomatic disease progression in advanced pancreatic cancer: A retrospective analysis.
Ma, Y. T., Hussain, S. A., Johnson, P. J., & Palmer, D. H. (2012). Gemcitabine chemotherapy until symptomatic disease progression in advanced pancreatic cancer: A retrospective analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30(4_suppl), 372.
2011
Decrease of serum protein concentration difference by solid-phase ligand libraries
Qi, Y. J., Niu, R. H., Wang, P., Hou, Y. F., Chao, W. X., Ma, Y. F., . . . Johnson, P. J. (2011). Decrease of serum protein concentration difference by solid-phase ligand libraries. Acta Anatomica Sinica, 42(6), 770-774. doi:10.3969/j.issn.0529-1356.2011.06.011
Justification for Sorafenib and Chemotherapy
Johnson, P. J. (2011). Justification for Sorafenib and Chemotherapy. In Unknown Book (pp. 154-159). Wiley. doi:10.1002/9781119962205.ch22
Cytotoxic Chemotherapy and Endocrine Therapy for Hepatocellular Carcinoma
Palmer, D., & Johnson, P. J. (2011). Cytotoxic Chemotherapy and Endocrine Therapy for Hepatocellular Carcinoma. In Hepatocellular Carcinoma: (pp. 337-353). Springer New York. doi:10.1007/978-1-60327-522-4_21
Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer
Bryan, R. T., Wei, W., Shimwell, N. J., Collins, S. I., Hussain, S. A., Billingham, L. J., . . . Ward, D. G. (2011). Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer. PROTEOMICS CLINICAL APPLICATIONS, 5(9-10), 493-503. doi:10.1002/prca.201100011
EFFECTIVENESS OF TRANS-ARTERIAL EMBOLISATION OF LIVER NEUROENDOCRINE TUMOUR METASTASES
Mandair, D. S., Bridgestock, H., Shah, T., Mangat, K., Olliff, S., Mahon, B., . . . Palmer, D. (2011). EFFECTIVENESS OF TRANS-ARTERIAL EMBOLISATION OF LIVER NEUROENDOCRINE TUMOUR METASTASES. In GUT Vol. 60. doi:10.1136/gut.2011.239301.243
Assessment of novel combinations of biomarkers for the detection of colorectal cancer.
Shimwell, N. J., Wei, W., Wilson, S., Wakelam, M. J. O., Ismail, T., Iqbal, T., . . . Ward, D. G. (2010). Assessment of novel combinations of biomarkers for the detection of colorectal cancer.. Cancer biomarkers : section A of Disease markers, 7(3), 123-132. doi:10.3233/cbm-2010-0155
Hepatobiliary tumours
Johnson, P. J. (2011). Hepatobiliary tumours. Medicine, 39(10), 630-633. doi:10.1016/j.mpmed.2011.07.009
Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.
Chan, S. L., Mo, F. K. F., Johnson, P. J., Liem, G. S., Chan, T. C., Poon, M. C., . . . Yeo, W. (2011). Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.. Journal of gastroenterology and hepatology, 26(2), 340-347. doi:10.1111/j.1440-1746.2010.06329.x
2010
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.
Abou-Alfa, G. K., Johnson, P., Knox, J. J., Capanu, M., Davidenko, I., Lacava, J., . . . Saltz, L. B. (2010). Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.. JAMA, 304(19), 2154-2160. doi:10.1001/jama.2010.1672
Detection of pancreatic adenocarcinoma using circulating fragments of fibrinogen.
Ward, D. G., Wei, W., Buckels, J., Taha, A. M. I., Hegab, B., Tariciotti, L., . . . Johnson, P. J. (2010). Detection of pancreatic adenocarcinoma using circulating fragments of fibrinogen.. European journal of gastroenterology & hepatology, 22(11), 1358-1363. doi:10.1097/meg.0b013e32833b6d41
10 Years of SELDI: What Have we Learnt?
Wei, W., Martin, A., Johnson, P., & Ward, D. (2010). 10 Years of SELDI: What Have we Learnt?. Current Proteomics, 7(1), 15-25. doi:10.2174/157016410790979617
Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference.
Dufour, J. -F., & Johnson, P. (2010). Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference.. In Journal of hepatology Vol. 52 (pp. 296-304). doi:10.1016/j.jhep.2009.11.010
2009
Confounding Effects of Benign Lung Diseases on Non-Small Cell Lung Cancer Serum Biomarker Discovery
Rathinam, S., Alzetani, A., Starczynski, J., Rajesh, P. B., Nyangoma, S., Wakelam, M. J. O., . . . Ward, D. G. (2009). Confounding Effects of Benign Lung Diseases on Non-Small Cell Lung Cancer Serum Biomarker Discovery. Clinical Proteomics, 5(3-4), 148-155. doi:10.1007/s12014-009-9033-4
Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.
Mohri, Y., Mohri, T., Wei, W., Qi, Y. -J., Martin, A., Miki, C., . . . Johnson, P. J. (2009). Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.. British journal of cancer, 101(2), 295-302. doi:10.1038/sj.bjc.6605138
TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance.
Wong, N., Yeo, W., Wong, W. -L., Wong, N. L. -Y., Chan, K. Y. -Y., Mo, F. K. -F., . . . To, K. -F. (2009). TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance.. International journal of cancer, 124(3), 644-652. doi:10.1002/ijc.23968
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.
Chan, S. L., Mo, F. K. F., Johnson, P. J., Hui, E. P., Ma, B. B. Y., Ho, W. M., . . . Yeo, W. (2009). New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27(3), 446-452. doi:10.1200/jco.2008.18.8151
Fast targeted multidimensional NMR metabolomics of colorectal cancer.
Ludwig, C., Ward, D. G., Martin, A., Viant, M. R., Ismail, T., Johnson, P. J., . . . Günther, U. L. (2009). Fast targeted multidimensional NMR metabolomics of colorectal cancer.. Magnetic resonance in chemistry : MRC, 47 Suppl 1, S68-S73. doi:10.1002/mrc.2519
Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison
Cairns, D. A., Barrett, J. H., Billingham, L. J., Stanley, A. J., Xinarianos, G., Field, J. K., . . . Banks, R. E. (2009). Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison. PROTEOMICS, 9(1), 74-86. doi:10.1002/pmic.200800417
Sorafenib for liver cancer: the horizon broadens.
Johnson, P., & Billingham, L. (2009). Sorafenib for liver cancer: the horizon broadens.. The Lancet. Oncology, 10(1), 4-5. doi:10.1016/s1470-2045(08)70317-6
2008
The clinical management of hepatic neoplasms
Palmer, D., & Johnson, P. (2008). The clinical management of hepatic neoplasms. In Interventional Radiological Treatment of Liver Tumors (pp. 1-24). Cambridge University Press. doi:10.1017/cbo9780511575433.003
SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard.
Ward, D. G., Roberts, K., Stonelake, P., Goon, P., Zampronio, C. G., Martin, A., . . . Tselepis, C. (2008). SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard.. Proteome science, 6, 28. doi:10.1186/1477-5956-6-28
Modelling prognostic factors in advanced pancreatic cancer.
Stocken, D. D., Hassan, A. B., Altman, D. G., Billingham, L. J., Bramhall, S. R., Johnson, P. J., & Freemantle, N. (2008). Modelling prognostic factors in advanced pancreatic cancer.. British journal of cancer, 99(6), 883-893. doi:10.1038/sj.bjc.6604568
Hepatocellular Carcinoma: Epidemiology, Pathology, Diagnosis and Screening
Johnson, P. (2008). Hepatocellular Carcinoma: Epidemiology, Pathology, Diagnosis and Screening. In Interventional Oncology (pp. 101-106). Cambridge University Press. doi:10.1017/cbo9780511722226.010
Hepatocellular Carcinoma: Medical Management
Johnson, P., & Palmer, D. (2008). Hepatocellular Carcinoma: Medical Management. In Interventional Oncology (pp. 115-120). Cambridge University Press. doi:10.1017/cbo9780511722226.012
Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer
Palmer, D. H., Stocken, D. D., Hewitt, H., Markham, C. E., Hassan, A. B., Johnson, P. J., . . . Bramhall, S. R. (2008). Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer. Annals of Surgical Oncology, 15(7), 2061. doi:10.1245/s10434-008-9921-2
Proteomic profiling of urine for the detection of colon cancer.
Ward, D. G., Nyangoma, S., Joy, H., Hamilton, E., Wei, W., Tselepis, C., . . . Martin, A. (2008). Proteomic profiling of urine for the detection of colon cancer.. Proteome science, 6, 19. doi:10.1186/1477-5956-6-19
Liver
Liver (2008). In Treatment of Cancer (pp. 583-596). CRC Press. doi:10.1201/b13550-29
Biology of hepatocellular carcinoma.
Pang, R. W. C., Joh, J. W., Johnson, P. J., Monden, M., Pawlik, T. M., & Poon, R. T. P. (2008). Biology of hepatocellular carcinoma.. In Annals of surgical oncology Vol. 15 (pp. 962-971). doi:10.1245/s10434-007-9730-z
Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy.
Thomas, M. B., O'Beirne, J. P., Furuse, J., Chan, A. T. C., Abou-Alfa, G., & Johnson, P. (2008). Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy.. In Annals of surgical oncology Vol. 15 (pp. 1008-1014). doi:10.1245/s10434-007-9705-0
2007
A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.
Palmer, D. H., Stocken, D. D., Hewitt, H., Markham, C. E., Hassan, A. B., Johnson, P. J., . . . Bramhall, S. R. (2007). A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.. Annals of surgical oncology, 14(7), 2088-2096. doi:10.1245/s10434-007-9384-x
A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity.
Mok, T. S. K., Yeo, W., Johnson, P. J., Hui, P., Ho, W. M., Lam, K. C., . . . Zee, B. (2007). A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity.. Annals of oncology : official journal of the European Society for Medical Oncology, 18(4), 768-774. doi:10.1093/annonc/mdl465
New medical options for liver tumours.
Williams, S., Palmer, D., & Johnson, P. (2007). New medical options for liver tumours.. Clinical medicine (London, England), 7(4), 351-356. doi:10.7861/clinmedicine.7-4-351
2006
Malignant Tumors of the Liver
JOHNSON, P. (2006). Malignant Tumors of the Liver. In Comprehensive Clinical Hepatology (pp. 453-472). Elsevier. doi:10.1016/b978-0-323-03675-7.50033-0
Preclinical and post-treatment changes in the HCC-associated serum proteome.
Ward, D. G., Cheng, Y., N'Kontchou, G., Thar, T. T., Barget, N., Wei, W., . . . Johnson, P. J. (2006). Preclinical and post-treatment changes in the HCC-associated serum proteome.. British journal of cancer, 95(10), 1379-1383. doi:10.1038/sj.bjc.6603429
A comparison of wound treatments in nasopharyngeal cancer patients receiving radiation therapy.
Mak, S. S., Zee, C. Y., Molassiotis, A., Chan, S. J., Leung, S. F., Mo, K. F., & Johnson, P. J. (2005). A comparison of wound treatments in nasopharyngeal cancer patients receiving radiation therapy.. Cancer nursing, 28(6), 436-445. doi:10.1097/00002820-200511000-00005
Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang, I. L., Poon, T. C. W., Lai, P. B. S., Chan, A. T. C., Ngai, S. -M., Hui, A. Y., . . . Sung, J. J. Y. (2006). Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.. Journal of proteome research, 5(10), 2691-2700. doi:10.1021/pr060109r
Principles of cancer treatment
Johnson, P. J. (2006). Principles of cancer treatment. In CardioVascular and Interventional Radiology Vol. 29 (pp. 158).
Novel identification of zyxin upregulations in the motile phenotype of hepatocellular carcinoma.
Sy, S. M. -H., Lai, P. B. -S., Pang, E., Wong, N. L. -Y., To, K. -F., Johnson, P. J., & Wong, N. (2006). Novel identification of zyxin upregulations in the motile phenotype of hepatocellular carcinoma.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 19(8), 1108-1116. doi:10.1038/modpathol.3800626
Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.
Yeo, W., Mo, F. K. F., Koh, J., Chan, A. T. C., Leung, T., Hui, P., . . . Zee, B. (2006). Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.. Annals of oncology : official journal of the European Society for Medical Oncology, 17(7), 1083-1089. doi:10.1093/annonc/mdl065
Identification of serum biomarkers for colon cancer by proteomic analysis.
Ward, D. G., Suggett, N., Cheng, Y., Wei, W., Johnson, H., Billingham, L. J., . . . Martin, A. (2006). Identification of serum biomarkers for colon cancer by proteomic analysis.. British journal of cancer, 94(12), 1898-1905. doi:10.1038/sj.bjc.6603188
Plasma proteome analysis reveals the geographical origin and liver tumor status of Dab (Limanda limanda) from UK marine waters.
Ward, D. G., Wei, W., Cheng, Y., Billingham, L. J., Martin, A., Johnson, P. I., . . . Stentiford, G. D. (2006). Plasma proteome analysis reveals the geographical origin and liver tumor status of Dab (Limanda limanda) from UK marine waters.. Environmental science & technology, 40(12), 4031-4036. doi:10.1021/es052436q
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.
Yeo, W., & Johnson, P. J. (2006). Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.. Hepatology (Baltimore, Md.), 43(2), 209-220. doi:10.1002/hep.21051
Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis.
Ward, D. G., Cheng, Y., N'Kontchou, G., Thar, T. T., Barget, N., Wei, W., . . . Johnson, P. J. (2006). Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis.. British journal of cancer, 94(2), 287-292. doi:10.1038/sj.bjc.6602923
A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data.
Poon, T. C. W., Wong, N., Lai, P. B. S., Rattray, M., Johnson, P. J., & Sung, J. J. Y. (2006). A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data.. Gastroenterology, 131(4), 1262-1270. doi:10.1053/j.gastro.2006.08.014
Chapter 29 Malignant Tumors of the Liver
Johnson, P. J. (2006). Chapter 29 Malignant Tumors of the Liver. In Comprehensive Clinical Hepatology (pp. 453-472). Elsevier. doi:10.1016/b978-0-323-03675-7.50033-0
2005
Control of malignant ascites with spironolactone.
Greenway, B., Johnson, P. J., & Williams, R. (1982). Control of malignant ascites with spironolactone.. The British journal of surgery, 69(8), 441-442. doi:10.1002/bjs.1800690802
Malignant Tumors of the Liver
Johnson, P. J. (2005). Malignant Tumors of the Liver. In Comprehensive Clinical Hepatology: Text with CD-ROM (pp. 453-472). doi:10.1016/B978-0-323-03675-7.50033-0
The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapy.
Greenway, B., Duke, D., Pym, B., Iqbal, M. J., Johnson, P. J., & Williams, R. (1982). The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapy.. The British journal of surgery, 69(10), 595-597. doi:10.1002/bjs.1800691013
Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma.
Poon, T. C. W., Chiu, C. H. S., Lai, P. B. S., Mok, T. S. K., Zee, B., Chan, A. T. C., . . . Johnson, P. J. (2005). Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma.. World journal of gastroenterology, 11(42), 6701-6706. doi:10.3748/wjg.v11.i42.6701
An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
Mok, T. S. K., Yeo, W., Yu, S., Lai, P., Chan, H. L. Y., Chan, A. T. C., . . . Johnson, P. J. (2005). An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23(31), 8041-8047. doi:10.1200/jco.2005.01.9927
Liver tumors in wild flatfish: a histopathological, proteomic, and metabolomic study.
Stentiford, G. D., Viant, M. R., Ward, D. G., Johnson, P. J., Martin, A., Wenbin, W., . . . Feist, S. W. (2005). Liver tumors in wild flatfish: a histopathological, proteomic, and metabolomic study.. Omics : a journal of integrative biology, 9(3), 281-299. doi:10.1089/omi.2005.9.281
A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.
Yeo, W., Mok, T. S., Zee, B., Leung, T. W. T., Lai, P. B. S., Lau, W. Y., . . . Johnson, P. J. (2005). A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.. Journal of the National Cancer Institute, 97(20), 1532-1538. doi:10.1093/jnci/dji315
Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.
Yeo, W., Hui, E. P., Chan, A. T. C., Ho, W. M., Lam, K. C., Chan, P. K. S., . . . Johnson, P. J. (2005). Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.. American journal of clinical oncology, 28(4), 379-384. doi:10.1097/01.coc.0000159554.97885.88
Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma.
Chan, K. Y. -Y., Wong, N., Lai, P. B. -S., Squire, J. A., Macgregor, P. F., Beheshti, B., . . . Johnson, P. J. (2005). Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma.. International journal of cancer, 114(6), 902-908. doi:10.1002/ijc.20684
Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma.
Sy, S. M. -H., Wong, N., Lai, P. B. -S., To, K. -F., & Johnson, P. J. (2005). Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 18(5), 686-692. doi:10.1038/modpathol.3800345
Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma.
Chan, A. T. C., Leung, S. F., Ngan, R. K. C., Teo, P. M. L., Lau, W. H., Kwan, W. H., . . . Zee, B. C. Y. (2005). Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma.. Journal of the National Cancer Institute, 97(7), 536-539. doi:10.1093/jnci/dji084
Gene- and immunotherapy for hepatocellular carcinoma
Palmer, D. H., Hussain, S. A., & Johnson, P. J. (2005). Gene- and immunotherapy for hepatocellular carcinoma. EXPERT OPINION ON BIOLOGICAL THERAPY, 5(4), 507-523. doi:10.1517/14712598.5.4.507
High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
Yeo, W., Wong, N., Wong, W. -L., Lai, P. B. S., Zhong, S., & Johnson, P. J. (2005). High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.. Liver international : official journal of the International Association for the Study of the Liver, 25(2), 266-272. doi:10.1111/j.1478-3231.2005.01084.x
Pre-operative locoregional therapy and liver transplantation for hepatocellular carcinoma: time for a randomized controlled trial.
Palmer, D. H., & Johnson, P. J. (2005). Pre-operative locoregional therapy and liver transplantation for hepatocellular carcinoma: time for a randomized controlled trial.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 5(4 Pt 1), 641-642. doi:10.1111/j.1600-6143.2005.00856.x
Clinical trial design in hepatocellular carcinoma.
Johnson, P. J., & Billingham, L. J. (2005). Clinical trial design in hepatocellular carcinoma.. Best practice & research. Clinical gastroenterology, 19(1), 119-127. doi:10.1016/j.bpg.2004.11.004
Non-surgical treatment of hepatocellular carcinoma.
Johnson, P. J. (2005). Non-surgical treatment of hepatocellular carcinoma.. HPB : the official journal of the International Hepato Pancreato Biliary Association, 7(1), 50-55. doi:10.1080/13651820410024076
2004
Systemic therapies for hepatocellular carcinoma
Palmer, D. H., Hussain, S. A., & Johnson, P. J. (2004). Systemic therapies for hepatocellular carcinoma. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 13(12), 1555-1568. doi:10.1517/13543784.13.12.1555
Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.
Yeo, W., Ho, W. M., Hui, P., Chan, P. K. S., Lam, K. C., Lee, J. J., & Johnson, P. J. (2004). Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.. Breast cancer research and treatment, 88(3), 209-215. doi:10.1007/s10549-004-0725-1
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.
Yeo, W., Lam, K. C., Zee, B., Chan, P. S. K., Mo, F. K. F., Ho, W. M., . . . Johnson, P. J. (2004). Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.. Annals of oncology : official journal of the European Society for Medical Oncology, 15(11), 1661-1666. doi:10.1093/annonc/mdh430
Technical evaluation of MALDI-TOF mass spectrometry for quantitative proteomic profiling matrix formulation and application
Pang, R. T. K., Johnson, P. J., Chan, C. M. L., Kong, E. K. C., Chan, A. T. C., Sung, J. J. Y., & Poon, T. C. W. (2004). Technical evaluation of MALDI-TOF mass spectrometry for quantitative proteomic profiling matrix formulation and application. Clinical Proteomics, 1(3-4), 259-270. doi:10.1385/cp:1:3-4:259
Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.
Chan, A. T. C., Ma, B. B. Y., Lo, Y. M. D., Leung, S. F., Kwan, W. H., Hui, E. P., . . . Zee, B. (2004). Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22(15), 3053-3060. doi:10.1200/jco.2004.05.178
A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer.
Mok, T. S. K., Leung, T. W. T., Brown, G., Moyses, C., Chan, A. T. C., Yeo, W., . . . Johnson, P. (2004). A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer.. Acta oncologica (Stockholm, Sweden), 43(3), 245-251. doi:10.1080/02841860310023525
Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung.
Sy, S. M. -H., Wong, N., Lee, T. -W., Tse, G., Mok, T. S. -K., Fan, B., . . . Yim, A. (2004). Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung.. European journal of cancer (Oxford, England : 1990), 40(7), 1082-1094. doi:10.1016/j.ejca.2004.01.012
Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors.
Chan, A. T. C., Tao, Q., Robertson, K. D., Flinn, I. W., Mann, R. B., Klencke, B., . . . Ambinder, R. F. (2004). Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22(8), 1373-1381. doi:10.1200/jco.2004.04.185
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy.
Yeo, W., Zee, B., Zhong, S., Chan, P. K. S., Wong, W. -L., Ho, W. M., . . . Johnson, P. J. (2004). Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy.. British journal of cancer, 90(7), 1306-1311. doi:10.1038/sj.bjc.6601699
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.
Yeo, W., Chan, P. K. S., Ho, W. M., Zee, B., Lam, K. C., Lei, K. I. K., . . . Johnson, P. J. (2004). Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22(5), 927-934. doi:10.1200/jco.2004.05.161
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nonnasopharyngeal head and neck carcinomas.
Yu, K. H., Lo, Y. M. D., Tse, G. M., Chan, K. C. A., Chan, A. B. W., Chow, K. C. K., . . . Chan, A. T. C. (2004). Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nonnasopharyngeal head and neck carcinomas.. Clinical cancer research : an official journal of the American Association for Cancer Research, 10(5), 1726-1732. doi:10.1158/1078-0432.ccr-0991-3
Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody.
Leung, S. -F., Tam, J. S., Chan, A. T. C., Zee, B., Chan, L. Y. S., Huang, D. P., . . . Lo, Y. M. D. (2004). Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody.. Clinical chemistry, 50(2), 339-345. doi:10.1373/clinchem.2003.022426
Psychosocial impact of breast cancer surgeries in Chinese patients and their spouses.
Yeo, W., Kwan, W. H., Teo, P. M. L., Nip, S., Wong, E., Hin, L. Y., & Johnson, P. J. (2004). Psychosocial impact of breast cancer surgeries in Chinese patients and their spouses.. Psycho-oncology, 13(2), 132-139. doi:10.1002/pon.777
False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
Mok, T. S. K., Yu, S. C. H., Lee, C., Sung, J., Leung, N., Lai, P., . . . Johnson, P. (2004). False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.. AJR. American journal of roentgenology, 183(2), 453-458. doi:10.2214/ajr.183.2.1830453
High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy.
Zhong, S., Yeo, W., Schroder, C., Chan, P. K. S., Wong, W. -L., Ho, W. M., . . . Johnson, P. J. (2004). High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy.. Journal of viral hepatitis, 11(1), 55-59. doi:10.1046/j.1352-0504.2003.00467.x
Nutritional consequences of radiotherapy in nasopharynx cancer patients.
Ng, K., Leung, S. F., Johnson, P. J., & Woo, J. (2004). Nutritional consequences of radiotherapy in nasopharynx cancer patients.. Nutrition and cancer, 49(2), 156-161. doi:10.1207/s15327914nc4902_6
2003
Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese.
Heneghan, M. A., Johnson, P. J., Clare, M., Ho, S., Harrison, P. M., & Donaldson, P. T. (2003). Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese.. International journal of gastrointestinal cancer, 34(1), 19-26. doi:10.1385/ijgc:34:1:19
HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.
Midgley, R. S., Bell, A. I., Yao, Q. Y., Croom-Carter, D., Hislop, A. D., Whitney, B. M., . . . Rickinson, A. B. (2003). HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.. Journal of virology, 77(21), 11507-11516. doi:10.1128/jvi.77.21.11507-11516.2003
Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
Ma, B. B. Y., Poon, T. C. W., To, K. F., Zee, B., Mo, F. K. F., Chan, C. M. L., . . . Chan, A. T. C. (2003). Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.. Head & neck, 25(10), 864-872. doi:10.1002/hed.10307
Quality of life of palliative care patients in the last two weeks of life.
Lo, R. S. K., Woo, J., Zhoc, K. C. H., Li, C. Y. P., Yeo, W., Johnson, P., . . . Lee, J. (2002). Quality of life of palliative care patients in the last two weeks of life.. Journal of pain and symptom management, 24(4), 388-397. doi:10.1016/s0885-3924(02)00504-3
Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2.
Leung, S. -F., Lo, Y. M. D., Chan, A. T. C., To, K. -F., To, E., Chan, L. Y. S., . . . Johnson, P. J. (2003). Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2.. Clinical cancer research : an official journal of the American Association for Cancer Research, 9(9), 3431-3434.
Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
Zhong, S., Yeo, W., Tang, M. W., Wong, N., Lai, P. B. S., & Johnson, P. J. (2003). Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.. Clinical cancer research : an official journal of the American Association for Cancer Research, 9(9), 3376-3382.
Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma.
To, E. W. H., Chan, K. C. A., Leung, S. -F., Chan, L. Y. S., To, K. -F., Chan, A. T. C., . . . Lo, Y. M. D. (2003). Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma.. Clinical cancer research : an official journal of the American Association for Cancer Research, 9(9), 3254-3259.
Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.
Yeo, W., Chan, P. K. S., Hui, P., Ho, W. M., Lam, K. C., Kwan, W. H., . . . Johnson, P. J. (2003). Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.. Journal of medical virology, 70(4), 553-561. doi:10.1002/jmv.10430
Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
Leung, S. -F., Chan, A. T. C., Zee, B., Ma, B., Chan, L. Y. S., Johnson, P. J., & Lo, Y. M. D. (2003). Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.. Cancer, 98(2), 288-291. doi:10.1002/cncr.11496
Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity.
Sy, S. M. H., Wong, N., Mok, T. S. K., Tsao, M. -S., Lee, T. -W., Tse, G., . . . Yim, A. P. (2003). Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity.. Lung cancer (Amsterdam, Netherlands), 41(1), 91-99. doi:10.1016/s0169-5002(03)00138-7
Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes.
Poon, T. C. W., Yip, T. -T., Chan, A. T. C., Yip, C., Yip, V., Mok, T. S. K., . . . Johnson, P. J. (2003). Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes.. Clinical chemistry, 49(5), 752-760. doi:10.1373/49.5.752
Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.
Wong, N., Chan, A., Lee, S. -W., Lam, E., To, K. -F., Lai, P. B. -S., . . . Johnson, P. J. (2003). Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.. Journal of hepatology, 38(3), 298-306. doi:10.1016/s0168-8278(02)00412-9
Phase II study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma.
Leung, T. W. T., Yu, S., Johnson, P. J., Geschwind, J., Vogl, T. J., Engelmann, K., . . . Thuluvath, P. J. (2003). Phase II study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21(4), 652-658. doi:10.1200/jco.2003.04.152
Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping.
Wong, N., Hui, A. B. Y., Fan, B., Lo, K. W., Pang, E., Leung, S. -F., . . . Johnson, P. J. (2003). Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping.. Cancer genetics and cytogenetics, 140(2), 124-132. doi:10.1016/s0165-4608(02)00657-x
A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma.
Hui, E. P., Poon, T. C. W., Teo, P. M. L., Mo, F., Zee, B., Leung, S. F., . . . Chan, A. T. C. (2003). A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 69(1), 53-62. doi:10.1016/s0167-8140(03)00248-2
Are there indications for chemotherapy in hepatocellular carcinoma?
Johnson, P. J. (2003). Are there indications for chemotherapy in hepatocellular carcinoma?. Surgical oncology clinics of North America, 12(1), 127-134. doi:10.1016/s1055-3207(02)00075-3
Critical issues in the design and implementation of clinical trials in hepatocellular carcinoma.
Johnson, P. J. (2003). Critical issues in the design and implementation of clinical trials in hepatocellular carcinoma.. Expert review of anticancer therapy, 3(4), 421-423. doi:10.1586/14737140.3.4.421
Nasopharyngeal cancer.
Chan, A. T. C., Teo, P. M. L., & Johnson, P. J. (2003). Nasopharyngeal cancer.. Cancer treatment and research, 114, 275-293. doi:10.1007/0-306-48060-3_11
Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Cheng, A. S. L., Chan, H. L. Y., Leung, W. K., Wong, N., Johnson, P. J., & Sung, J. J. Y. (2003). Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.. International journal of oncology, 23(1), 113-119.
2002
Phase II study of combination cisplatin and adriamycin in recurrent carcinoma of the nasopharynx
Yeo, W., Leung, T. W. T., Chan, A. T. C., Chiu, K. W., Yu, P., Mok, T., & Johnson, P. J. (2002). Phase II study of combination cisplatin and adriamycin in recurrent carcinoma of the nasopharynx. Oncology Forum, 6(1), 10-13.
Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese.
Chan, A. S. C., To, K. F., Lo, K. W., Ding, M., Li, X., Johnson, P., & Huang, D. P. (2002). Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese.. International journal of cancer, 102(3), 300-303. doi:10.1002/ijc.10689
Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.
Chan, A. T. C., Lo, Y. M. D., Zee, B., Chan, L. Y. S., Ma, B. B. Y., Leung, S. -F., . . . Johnson, P. J. (2002). Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.. Journal of the National Cancer Institute, 94(21), 1614-1619. doi:10.1093/jnci/94.21.1614
Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma.
Wong, N., Li, L., Tsang, K., Lai, P. B. -S., To, K. -F., & Johnson, P. J. (2002). Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma.. Journal of hepatology, 37(5), 633-639. doi:10.1016/s0168-8278(02)00269-6
High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.
Chow, P. K. H., Tai, B. -C., Tan, C. -K., Machin, D., Win, K. M., Johnson, P. J., . . . Asian-Pacific Hepatocellular Carcinoma Trials Group. (2002). High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.. Hepatology (Baltimore, Md.), 36(5), 1221-1226. doi:10.1053/jhep.2002.36824
Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.
Leung, T. H. -Y., Wong, N., Lai, P. B. -S., Chan, A., To, K. -F., Liew, C. -T., . . . Johnson, P. J. (2002). Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 15(11), 1213-1220. doi:10.1097/01.mp.0000036347.66943.3c
A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
Mok, T. S. K., Wong, H., Zee, B., Yu, K. H., Leung, T. W. T., Lee, T. W., . . . Johnson, P. (2002). A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.. Cancer, 95(7), 1511-1519. doi:10.1002/cncr.10836
Hepatocellular carcinoma: is current therapy really altering outcome?
Johnson, P. J. (2002). Hepatocellular carcinoma: is current therapy really altering outcome?. Gut, 51(4), 459-462. doi:10.1136/gut.51.4.459
Nasopharyngeal carcinoma.
Chan, A. T. C., Teo, P. M. L., & Johnson, P. J. (2002). Nasopharyngeal carcinoma.. Annals of oncology : official journal of the European Society for Medical Oncology, 13(7), 1007-1015. doi:10.1093/annonc/mdf179
Differential expression of the suppressor PML and Ki-67 identifies three subtypes of human nasopharyngeal carcinoma.
Chan, J. Y. H., Meng, C. L., To, K. F., Leung, S. F., Chan, A. T. C., Lee, K. K. H., & Johnson, P. J. (2002). Differential expression of the suppressor PML and Ki-67 identifies three subtypes of human nasopharyngeal carcinoma.. European journal of cancer (Oxford, England : 1990), 38(12), 1600-1606. doi:10.1016/s0959-8049(02)00080-1
Plasma nucleic acids in the diagnosis and management of malignant disease.
Johnson, P. J., & Lo, Y. M. D. (2002). Plasma nucleic acids in the diagnosis and management of malignant disease.. Clinical chemistry, 48(8), 1186-1193.
Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.
Ng, E. K. O., Tsui, N. B. Y., Lam, N. Y. L., Chiu, R. W. K., Yu, S. C. H., Wong, S. C. C., . . . Lo, Y. M. D. (2002). Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.. Clinical chemistry, 48(8), 1212-1217.
Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein.
Poon, T. C. W., Mok, T. S. K., Chan, A. T. C., Chan, C. M. L., Leong, V., Tsui, S. H. T., . . . Johnson, P. J. (2002). Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein.. Clinical chemistry, 48(7), 1021-1027.
Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients.
Whitney, B. M., Chan, A. T. C., Rickinson, A. B., Lee, S. P., Lin, C. K., & Johnson, P. J. (2002). Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients.. Journal of medical virology, 67(3), 359-363. doi:10.1002/jmv.10073
Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer -- a retrospective review of Chinese patients and comparison with an historic Western series.
Ma, B., Yeo, W., Hui, P., Ho, W. M., & Johnson, P. J. (2002). Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer -- a retrospective review of Chinese patients and comparison with an historic Western series.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 62(2), 185-189. doi:10.1016/s0167-8140(02)00003-8
Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial.
Chan, A. T. C., Teo, P. M. L., Ngan, R. K., Leung, T. W., Lau, W. H., Zee, B., . . . Johnson, P. J. (2002). Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20(8), 2038-2044. doi:10.1200/jco.2002.08.149
Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
Zhong, S., Tang, M. W., Yeo, W., Liu, C., Lo, Y. M. D., & Johnson, P. J. (2002). Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.. Clinical cancer research : an official journal of the American Association for Cancer Research, 8(4), 1087-1092.
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.
Leung, T. W. T., Tang, A. M. Y., Zee, B., Lau, W. Y., Lai, P. B. S., Leung, K. L., . . . Johnson, P. J. (2002). Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.. Cancer, 94(6), 1760-1769. doi:10.1002/cncr.10384
Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
Lei, K. I. K., Chan, L. Y. S., Chan, W. -Y., Johnson, P. J., & Lo, Y. M. D. (2002). Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.. Clinical cancer research : an official journal of the American Association for Cancer Research, 8(1), 29-34.
Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
Kwong, J., Lo, K. -W., To, K. -F., Teo, P. M. L., Johnson, P. J., & Huang, D. P. (2002). Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.. Clinical cancer research : an official journal of the American Association for Cancer Research, 8(1), 131-137.
Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines.
Pang, E., Wong, N., Lai, P. B. -S., To, K. -F., Lau, W. -Y., & Johnson, P. J. (2002). Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines.. Genes, chromosomes & cancer, 33(2), 150-159. doi:10.1002/gcc.1220
Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.
Leung, T. W. T., Tang, A. M. Y., Zee, B., Yu, S. C. H., Lai, P. B. S., Lau, W. Y., & Johnson, P. J. (2002). Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.. Cancer, 94(2), 421-427. doi:10.1002/cncr.10236
Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui, E. P., Chan, A. T. C., Pezzella, F., Turley, H., To, K. -F., Poon, T. C. W., . . . Harris, A. L. (2002). Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.. Clinical cancer research : an official journal of the American Association for Cancer Research, 8(8), 2595-2604.
Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients.
Zhong, S., Yeo, W., Tang, M., Liu, C., Lin, X. -R., Ho, W. M., . . . Johnson, P. J. (2002). Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients.. Journal of medical virology, 66(3), 428-434. doi:10.1002/jmv.2163
Introduction: nasopharyngeal cancer
Huang, D. P., & Johnson, P. J. (2002). Introduction: nasopharyngeal cancer. In Seminars in Cancer Biology Vol. 12 (pp. 419). Elsevier BV. doi:10.1016/s1044579x02000846
Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer.
Yeo, W., Mok, T. S. K., Tse, K. K., Kwan, W. H., Lam, K. C., Ho, W. M., . . . Johnson, P. J. (2002). Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer.. Anti-cancer drugs, 13(6), 655-662. doi:10.1097/00001813-200207000-00013
Screening for hepatocellular carcinoma--answers to some simple questions.
Johnson, P. J. (2002). Screening for hepatocellular carcinoma--answers to some simple questions.. The American journal of gastroenterology, 97(2), 225-226. doi:10.1111/j.1572-0241.2002.05448.x
The molecular biology of hepatitis B virus-associated hepatocellular carcinoma
Johnson, P. J. (2002). The molecular biology of hepatitis B virus-associated hepatocellular carcinoma. Unknown Journal, 101-111. doi:10.1016/s0168-7069(02)06069-x
2001
Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
Poon, T. C., Chan, A. T., Zee, B., Ho, S. K., Mok, T. S., Leung, T. W., & Johnson, P. J. (2001). Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.. Oncology, 61(4), 275-283. doi:10.1159/000055334
Prevalence of breast cancer predisposition gene mutations in Chinese women and guidelines for genetic testing.
Tang, N. L., Choy, K. W., Pang, C. P., Yeo, W., & Johnson, P. J. (2001). Prevalence of breast cancer predisposition gene mutations in Chinese women and guidelines for genetic testing.. In Clinica chimica acta; international journal of clinical chemistry Vol. 313 (pp. 179-185). doi:10.1016/s0009-8981(01)00671-4
Proteome analysis and its impact on the discovery of serological tumor markers.
Poon, T. C., & Johnson, P. J. (2001). Proteome analysis and its impact on the discovery of serological tumor markers.. In Clinica chimica acta; international journal of clinical chemistry Vol. 313 (pp. 231-239). doi:10.1016/s0009-8981(01)00677-5
Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis.
Yeo, W., Chan, P. K., Chan, H. L., Mo, F. K., & Johnson, P. J. (2001). Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis.. Journal of medical virology, 65(3), 473-477. doi:10.1002/jmv.2060
Quantitative and genotypic analysis of TT virus infection in Chinese blood donors.
Zhong, S., Yeo, W., Lin, C. K., Lin, X. R., Tang, M. W., & Johnson, P. J. (2001). Quantitative and genotypic analysis of TT virus infection in Chinese blood donors.. Transfusion, 41(8), 1001-1007. doi:10.1046/j.1537-2995.2001.41081001.x
The use of brush cytology and directed biopsies for the detection of nasopharyngeal carcinoma and precursor lesions.
Chang, A. R., Liang, X. M., Chan, A. T., Chan, M. K., Teo, P. M., & Johnson, P. J. (2001). The use of brush cytology and directed biopsies for the detection of nasopharyngeal carcinoma and precursor lesions.. Head & neck, 23(8), 637-645. doi:10.1002/hed.1090
Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.
Wong, I. H., Yeo, W., Leung, T., Lau, W. Y., & Johnson, P. J. (2001). Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.. Cancer letters, 167(2), 183-191. doi:10.1016/s0304-3835(01)00455-4
Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
Mok, T. S., Kanekal, S., Lin, X. R., Leung, T. W., Chan, A. T., Yeo, W., . . . Johnson, P. (2001). Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.. Cancer, 91(12), 2369-2377. doi:3.0.co;2-3">10.1002/1097-0142(20010615)91:12<2369::aid-cncr1270>3.0.co;2-3
HLA class II alleles in Chinese patients with hepatocellular carcinoma.
Donaldson, P. T., Ho, S., Williams, R., & Johnson, P. J. (2001). HLA class II alleles in Chinese patients with hepatocellular carcinoma.. Liver, 21(2), 143-148. doi:10.1034/j.1600-0676.2001.021002143.x
High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
Lo, K. W., Kwong, J., Hui, A. B., Chan, S. Y., To, K. F., Chan, A. S., . . . Huang, D. P. (2001). High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.. Cancer research, 61(10), 3877-3881.
What determines survival duration in hepatocellular carcinoma treated with intraarterial Yttrium-90 microspheres?
Lau, W. Y., Ho, S., Leung, W. T., Chan, M., Lee, W. Y., & Johnson, P. J. (2001). What determines survival duration in hepatocellular carcinoma treated with intraarterial Yttrium-90 microspheres?. Hepato-gastroenterology, 48(38), 338-340.
Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression.
Wong, I. H., Yeo, W., Chan, A. T., & Johnson, P. J. (2001). Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression.. Cancer letters, 162(1), 65-73. doi:10.1016/s0304-3835(00)00630-3
A framework for the molecular classification of circulating tumor markers.
Johnson, P. J. (2001). A framework for the molecular classification of circulating tumor markers.. In Annals of the New York Academy of Sciences Vol. 945 (pp. 8-21). doi:10.1111/j.1749-6632.2001.tb03859.x
Circulating cell-free Epstein-Barr virus DNA levels in patients with EBV-associated lymphoid malignancies.
Lei, K. I., Chan, L. Y., Chan, W. Y., Johnson, P. J., & Lo, Y. M. (2001). Circulating cell-free Epstein-Barr virus DNA levels in patients with EBV-associated lymphoid malignancies.. In Annals of the New York Academy of Sciences Vol. 945 (pp. 80-83). doi:10.1111/j.1749-6632.2001.tb03867.x
Cross-cultural validation of the McGill Quality of Life questionnaire in Hong Kong Chinese.
Lo, R. S., Woo, J., Zhoc, K. C., Li, C. Y., Yeo, W., Johnson, P., . . . Lee, J. (2001). Cross-cultural validation of the McGill Quality of Life questionnaire in Hong Kong Chinese.. Palliative medicine, 15(5), 387-397. doi:10.1191/026921601680419438
Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring.
Wong, I. H., Lo, Y. M., & Johnson, P. J. (2001). Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring.. In Annals of the New York Academy of Sciences Vol. 945 (pp. 36-50).
Genetic imbalances in pT2 breast cancers of southern Chinese women.
Fung, L. F., Wong, N., Tang, N., Lau, A., Wong, V., Pang, C. P., . . . Johnson, P. J. (2001). Genetic imbalances in pT2 breast cancers of southern Chinese women.. Cancer genetics and cytogenetics, 124(1), 56-61. doi:10.1016/s0165-4608(00)00328-9
Gross elevation of TT virus genome load in the peripheral blood mononuclear cells of cancer patients.
Zhong, S., Yeo, W., Tang, M. W., Lin, X. R., Mo, F., Ho, W. M., . . . Johnson, P. J. (2001). Gross elevation of TT virus genome load in the peripheral blood mononuclear cells of cancer patients.. In Annals of the New York Academy of Sciences Vol. 945 (pp. 84-92). doi:10.1111/j.1749-6632.2001.tb03868.x
Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.
Wong, N., Lam, W. C., Lai, P. B., Pang, E., Lau, W. Y., & Johnson, P. J. (2001). Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.. The American journal of pathology, 159(2), 465-471. doi:10.1016/s0002-9440(10)61718-x
Management of hepatoma using cisplatin/epinephrine gel in patients awaiting orthotopic liver transplantation.
Thuluvath, P. J., Geschwind, J. F., Johnson, P. J., Heneghan, M. A., & O'Grady, J. (2001). Management of hepatoma using cisplatin/epinephrine gel in patients awaiting orthotopic liver transplantation.. Transplantation proceedings, 33(1-2), 1359-1360. doi:10.1016/s0041-1345(00)02510-0
Quantitative correlation of cytokeratin 19 mRNA level in peripheral blood with disease stage and metastasis in breast cancer patients: potential prognostic implications.
Wong, I. H., Yeo, W., Chan, A. T., & Johnson, P. J. (2001). Quantitative correlation of cytokeratin 19 mRNA level in peripheral blood with disease stage and metastasis in breast cancer patients: potential prognostic implications.. International journal of oncology, 18(3), 633-638. doi:10.3892/ijo.18.3.633
Systemic therapy for hepatocellular carcinoma.
Leung, T. W., & Johnson, P. J. (2001). Systemic therapy for hepatocellular carcinoma.. Seminars in oncology, 28(5), 514-520. doi:10.1016/s0093-7754(01)90144-7
The cost of palliative care for hepatocellular carcinoma in Hong Kong.
Chan, A. T., Jacobs, P., Yeo, W., Lai, M., Hazlett, C. B., Mok, T. S., . . . Johnson, P. J. (2001). The cost of palliative care for hepatocellular carcinoma in Hong Kong.. PharmacoEconomics, 19(9), 947-953. doi:10.2165/00019053-200119090-00006
The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma.
Johnson, P. J. (2001). The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma.. Clinics in liver disease, 5(1), 145-159. doi:10.1016/s1089-3261(05)70158-6
2000
Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.
Lo, Y. M., Chan, A. T., Chan, L. Y., Leung, S. F., Lam, C. W., Huang, D. P., & Johnson, P. J. (2000). Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.. Cancer research, 60(24), 6878-6881.
Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy.
Yeo, W., Zhong, S., Chan, P. K., Ho, W. M., Wong, H. T., Chan, A. S., & Johnson, P. J. (2000). Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy.. Journal of viral hepatitis, 7(6), 448-458. doi:10.1046/j.1365-2893.2000.00257.x
Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications.
Teo, P. M., Leung, S. F., Chan, A. T., Leung, T. W., Choi, P. H., Kwan, W. H., . . . Johnson, P. J. (2000). Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications.. International journal of radiation oncology, biology, physics, 48(5), 1311-1322. doi:10.1016/s0360-3016(00)00786-0
Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies.
Lei, K. I., Chan, L. Y., Chan, W. Y., Johnson, P. J., & Lo, Y. M. (2000). Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies.. British journal of haematology, 111(1), 239-246. doi:10.1046/j.1365-2141.2000.02344.x
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.
Yeo, W., Chan, P. K., Zhong, S., Ho, W. M., Steinberg, J. L., Tam, J. S., . . . Johnson, P. J. (2000). Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.. Journal of medical virology, 62(3), 299-307. doi:3.0.co;2-0">10.1002/1096-9071(200011)62:3<299::aid-jmv1>3.0.co;2-0
Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.
Wong, I. H., Lo, Y. M., Yeo, W., Lau, W. Y., & Johnson, P. J. (2000). Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.. Clinical cancer research : an official journal of the American Association for Cancer Research, 6(9), 3516-3521.
The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas.
Lei, K. I., & Johnson, P. J. (2000). The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas.. Cancer, 89(6), 1387-1395. doi:3.0.co;2-3">10.1002/1097-0142(20000915)89:6<1387::aid-cncr24>3.0.co;2-3
Alpha-fetoprotein variants in a case of pancreatoblastoma.
Chan, M. H., Shing, M. M., Poon, T. C., Johnson, P. J., & Lam, C. W. (2000). Alpha-fetoprotein variants in a case of pancreatoblastoma.. Annals of clinical biochemistry, 37 ( Pt 5), 681-685. doi:10.1258/0004563001899942
Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients.
Wong, I. H., Lo, Y. M., Lai, P. B., & Johnson, P. J. (2000). Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients.. Clinical chemistry, 46(9), 1420-1422.
Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring.
Wong, I. H., Lau, W. Y., Leung, T., & Johnson, P. J. (2000). Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring.. Cancer letters, 156(2), 141-149. doi:10.1016/s0304-3835(00)00473-0
A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma.
Mok, T. S., Zee, B., Chan, A. T., Yeo, W., Yang, W. T., Yim, A., . . . Johnson, P. (2000). A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma.. Cancer, 89(3), 543-550. doi:3.0.co;2-v">10.1002/1097-0142(20000801)89:3<543::aid-cncr9>3.0.co;2-v
CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells.
Lee, S. P., Chan, A. T., Cheung, S. T., Thomas, W. A., CroomCarter, D., Dawson, C. W., . . . Huang, D. P. (2000). CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells.. Journal of immunology (Baltimore, Md. : 1950), 165(1), 573-582. doi:10.4049/jimmunol.165.1.573
Presence of mitochondrial tRNA(Leu(UUR)) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus.
Zhong, S., Ng, M. C., Lo, Y. M., Chan, J. C., & Johnson, P. J. (2000). Presence of mitochondrial tRNA(Leu(UUR)) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus.. Journal of clinical pathology, 53(6), 466-469. doi:10.1136/jcp.53.6.466
Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study.
Wong, I. H., Chan, A. T., & Johnson, P. J. (2000). Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study.. Clinical cancer research : an official journal of the American Association for Cancer Research, 6(6), 2183-2188.
Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma.
Lo, Y. M., Leung, S. F., Chan, L. Y., Chan, A. T., Lo, K. W., Johnson, P. J., & Huang, D. P. (2000). Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma.. Cancer research, 60(9), 2351-2355.
Chemotherapy for Unresectable Liver Cancer
Johnson, P. J. (2000). Chemotherapy for Unresectable Liver Cancer. In Asian Journal of Surgery Vol. 23 (pp. 9). Springer Science and Business Media LLC. doi:10.1007/s101160050003
Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues.
Zhong, S., Chan, J. Y., Yeo, W., Tam, J. S., & Johnson, P. J. (2000). Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues.. Journal of viral hepatitis, 7(2), 115-123. doi:10.1046/j.1365-2893.2000.00209.x
Lack of expression for the suppressor PML in human small cell lung carcinoma.
Zhang, P., Chin, W., Chow, L. T., Chan, A. S., Yim, A. P., Leung, S. F., . . . Chan, J. Y. (2000). Lack of expression for the suppressor PML in human small cell lung carcinoma.. International journal of cancer, 85(5), 599-605. doi:3.0.co;2-#">10.1002/(sici)1097-0215(20000301)85:5<599::aid-ijc1>3.0.co;2-#
Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
Steinberg, J. L., Yeo, W., Zhong, S., Chan, J. Y., Tam, J. S., Chan, P. K., . . . Johnson, P. J. (2000). Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.. Journal of medical virology, 60(3), 249-255. doi:3.0.co;2-c">10.1002/(sici)1096-9071(200003)60:3<249::aid-jmv1>3.0.co;2-c
Novel intertypic recombinants of epstein-barr virus in the chinese population.
Midgley, R. S., Blake, N. W., Yao, Q. Y., Croom-Carter, D., Cheung, S. T., Leung, S. F., . . . Lee, S. P. (2000). Novel intertypic recombinants of epstein-barr virus in the chinese population.. Journal of virology, 74(3), 1544-1548. doi:10.1128/jvi.74.3.1544-1548.2000
A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization.
Pang, E., Wong, N., Lai, P. B., To, K. F., Lau, J. W., & Johnson, P. J. (2000). A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization.. Cancer genetics and cytogenetics, 121(1), 9-16. doi:10.1016/s0165-4608(99)00247-2
Chromosomal translocations are common in natural killer-cell lymphoma/leukemia as shown by spectral karyotyping.
Wong, N., Wong, K. F., Chan, J. K., & Johnson, P. J. (2000). Chromosomal translocations are common in natural killer-cell lymphoma/leukemia as shown by spectral karyotyping.. Human pathology, 31(6), 771-774. doi:10.1053/hupa.2000.7625
Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma.
Fan, C. S., Wong, N., Leung, S. F., To, K. F., Lo, K. W., Lee, S. W., . . . Huang, D. P. (2000). Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma.. In Human pathology Vol. 31 (pp. 169-178). doi:10.1016/s0046-8177(00)80216-6
Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
Wong, N., Lai, P., Pang, E., Fung, L. F., Sheng, Z., Wong, V., . . . Johnson, P. J. (2000). Genomic aberrations in human hepatocellular carcinomas of differing etiologies.. Clinical cancer research : an official journal of the American Association for Cancer Research, 6(10), 4000-4009.
Hepatocellular carcinoma and the art of prognostication.
Johnson, P., & Bruix, J. (2000). Hepatocellular carcinoma and the art of prognostication.. Journal of hepatology, 33(6), 1006-1008. doi:10.1016/s0168-8278(00)80137-3
Molecular analysis of circulating tumor cells in peripheral blood from patients with germ cell tumor: a quantitative approach.
Wong, I. H., Chan, A. T., & Johnson, P. J. (2000). Molecular analysis of circulating tumor cells in peripheral blood from patients with germ cell tumor: a quantitative approach.. International journal of molecular medicine, 6(4), 491-494. doi:10.3892/ijmm.6.4.491
Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging.
Lo, Y. M., Leung, S. F., Chan, L. Y., Lo, K. W., Zhang, J., Chan, A. T., . . . Huang, D. P. (2000). Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging.. In Annals of the New York Academy of Sciences Vol. 906 (pp. 99-101). doi:10.1111/j.1749-6632.2000.tb06597.x
Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management.
Yeo, W., & Johnson, P. J. (2000). Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management.. American journal of clinical dermatology, 1(2), 113-116. doi:10.2165/00128071-200001020-00006
Structures of disease-specific serum alpha-fetoprotein isoforms.
Johnson, P. J., Poon, T. C., Hjelm, N. M., Ho, C. S., Blake, C., & Ho, S. K. (2000). Structures of disease-specific serum alpha-fetoprotein isoforms.. British journal of cancer, 83(10), 1330-1337. doi:10.1054/bjoc.2000.1441
TT virus: a study of molecular epidemiology and transmission of genotypes 1, 2 and 3.
Gallian, P., Biagini, P., Zhong, S., Touinssi, M., Yeo, W., Cantaloube, J. F., . . . de Lamballerie, X. (2000). TT virus: a study of molecular epidemiology and transmission of genotypes 1, 2 and 3.. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 17(1), 43-49. doi:10.1016/s1386-6532(00)00066-4
Tumor-derived epigenetic changes in the plasma and serum of liver cancer patients. Implications for cancer detection and monitoring.
Wong, I. H., Johnson, P. J., Lai, P. B., Lau, W. Y., & Lo, Y. M. (2000). Tumor-derived epigenetic changes in the plasma and serum of liver cancer patients. Implications for cancer detection and monitoring.. In Annals of the New York Academy of Sciences Vol. 906 (pp. 102-105). doi:10.1111/j.1749-6632.2000.tb06598.x
1999
Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
Wong, I. H., Lau, W. Y., Leung, T., Yeo, W., & Johnson, P. J. (1999). Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.. Clinical cancer research : an official journal of the American Association for Cancer Research, 5(12), 4021-4027.
Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.
Lo, Y. M., Chan, L. Y., Chan, A. T., Leung, S. F., Lo, K. W., Zhang, J., . . . Huang, D. P. (1999). Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.. Cancer research, 59(21), 5452-5455.
Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.
Yeo, W., Steinberg, J. L., Tam, J. S., Chan, P. K., Leung, N. W., Lam, K. C., . . . Johnson, P. J. (1999). Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.. Journal of medical virology, 59(3), 263-269. doi:3.0.co;2-x">10.1002/(sici)1096-9071(199911)59:3<263::aid-jmv1>3.0.co;2-x
A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma.
Mok, T. S., Leung, T. W., Lee, S. D., Chao, Y., Chan, A. T., Huang, A., . . . Johnson, P. (1999). A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma.. Cancer chemotherapy and pharmacology, 44(4), 307-311. doi:10.1007/s002800050982
Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma.
Lo, K. W., Lo, Y. M., Leung, S. F., Tsang, Y. S., Chan, L. Y., Johnson, P. J., . . . Huang, D. P. (1999). Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma.. Clinical chemistry, 45(8 Pt 1), 1292-1294.
Translocation (5;19)(q33;q13) as the sole abnormality in a case of refractory anemia with excess of blasts in transformation.
Wong, N., Yeo, W., Yuen, J., & Johnson, P. J. (1999). Translocation (5;19)(q33;q13) as the sole abnormality in a case of refractory anemia with excess of blasts in transformation.. Cancer genetics and cytogenetics, 112(2), 186-187. doi:10.1016/s0165-4608(98)00270-2
Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.
Leung, T. W., Patt, Y. Z., Lau, W. Y., Ho, S. K., Yu, S. C., Chan, A. T., . . . Johnson, P. J. (1999). Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.. Clinical cancer research : an official journal of the American Association for Cancer Research, 5(7), 1676-1681.
Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes.
Yeo, W., Chan, K. K., Mukwaya, G., Ross, M., Leung, W. T., Ho, S., . . . Johnson, P. J. (1999). Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes.. Cancer chemotherapy and pharmacology, 44(2), 124-130. doi:10.1007/s002800050956
Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer.
Tang, N. L., Pang, C. P., Yeo, W., Choy, K. W., Lam, P. K., Suen, M., . . . Hjelm, M. (1999). Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer.. Journal of the National Cancer Institute, 91(10), 882-885. doi:10.1093/jnci/91.10.882
Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.
Zhong, S., Chan, J. Y., Yeo, W., Tam, J. S., & Johnson, P. J. (1999). Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.. Journal of viral hepatitis, 6(3), 195-202. doi:10.1046/j.1365-2893.1999.00154.x
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.
Lo, Y. M., Chan, L. Y., Lo, K. W., Leung, S. F., Zhang, J., Chan, A. T., . . . Huang, D. P. (1999). Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.. Cancer research, 59(6), 1188-1191.
Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.
Lau, W. Y., Leung, T. W., Ho, S. K., Chan, M., Machin, D., Lau, J., . . . Johnson, P. J. (1999). Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.. Lancet (London, England), 353(9155), 797-801. doi:10.1016/s0140-6736(98)06475-7
Increased incidence of tongue cancer after primary radiotherapy for nasopharyngeal carcinoma--the possibility of radiation carcinogenesis.
Teo, P. M., Chan, A. T., Leung, S. F., Chau, R. M., Yu, P. K., King, W. W., & Johnson, P. J. (1999). Increased incidence of tongue cancer after primary radiotherapy for nasopharyngeal carcinoma--the possibility of radiation carcinogenesis.. European journal of cancer (Oxford, England : 1990), 35(2), 219-225. doi:10.1016/s0959-8049(98)00386-4
Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
Teo, P. M., Chan, A. T., Lee, W. Y., Leung, T. W., & Johnson, P. J. (1999). Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.. International journal of radiation oncology, biology, physics, 43(2), 261-271. doi:10.1016/s0360-3016(98)00383-6
Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.
Wong, N., Lai, P., Lee, S. W., Fan, S., Pang, E., Liew, C. T., . . . Johnson, P. J. (1999). Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.. The American journal of pathology, 154(1), 37-43. doi:10.1016/s0002-9440(10)65248-0
Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
Su, X. Y., Wong, N., Cao, Q., Yu, L. Z., Niu, C., Wickham, N., . . . Chen, S. J. (1999). Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.. Cancer genetics and cytogenetics, 108(1), 6-12. doi:10.1016/s0165-4608(98)00120-4
Combating hepatocellular carcinoma with an integrated approach.
Ho, S., Johnson, P. J., Leung, W. T., & Lau, W. Y. (1999). Combating hepatocellular carcinoma with an integrated approach.. Chinese medical journal, 112(1), 80-83.
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
Wong, I. H., Lo, Y. M., Zhang, J., Liew, C. T., Ng, M. H., Wong, N., . . . Johnson, P. J. (1999). Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.. Cancer research, 59(1), 71-73.
Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.
Johnson, P. J., Poon, T. C., Hjelm, N. M., Ho, C. S., Ho, S. K., Welby, C., . . . Townsend, R. R. (1999). Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.. British journal of cancer, 81(7), 1188-1195. doi:10.1038/sj.bjc.6690828
Monitoring response to treatment in liver tumours.
Yang, W. T., & Johnson, P. J. (1999). Monitoring response to treatment in liver tumours.. Bailliere's best practice & research. Clinical gastroenterology, 13(4), 637-654. doi:10.1053/bega.1999.0053
Preface
Johnson, P. J. (1999). Preface. Best Practice & Research Clinical Gastroenterology, 13(4), vii-viii. doi:10.1053/bega.1999.0043
Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma.
Johnson, P. J. (1999). Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma.. Journal of gastroenterology and hepatology, 14 Suppl, S32-S36. doi:10.1046/j.1440-1746.1999.01873.x
1998
A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma.
Yeo, W., Leung, T. W., Chan, A. T., Chiu, S. K., Yu, P., Mok, T. S., & Johnson, P. J. (1998). A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma.. European journal of cancer (Oxford, England : 1990), 34(13), 2027-2031. doi:10.1016/s0959-8049(98)00280-9
Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review.
Ho, S., Lau, W. Y., Leung, T. W., & Johnson, P. J. (1998). Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review.. Cancer, 83(9), 1894-1907. doi:3.0.co;2-o">10.1002/(sici)1097-0142(19981101)83:9<1894::aid-cncr4>3.0.co;2-o
Staging and IgA VCA titre in patients with nasopharyngeal carcinoma: changes over a 12-year period.
Ho, S., Teo, P., Kwan, W. H., Choi, P., Tjong, J., & Johnson, P. J. (1998). Staging and IgA VCA titre in patients with nasopharyngeal carcinoma: changes over a 12-year period.. Oral oncology, 34(6), 491-495. doi:10.1016/s1368-8375(98)00063-3
Multimodality treatment of primary lymphoepithelioma-like carcinoma of the lung.
Chan, A. T., Teo, P. M., Lam, K. C., Chan, W. Y., Chow, J. H., Yim, A. P., . . . Johnson, P. J. (1998). Multimodality treatment of primary lymphoepithelioma-like carcinoma of the lung.. Cancer, 83(5), 925-929. doi:3.0.co;2-x">10.1002/(sici)1097-0142(19980901)83:5<925::aid-cncr18>3.0.co;2-x
Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma.
Chan, A. T., Leung, T. W., Kwan, W. H., Mok, T. S., Yeo, W., Lai, M., & Johnson, P. J. (1998). Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma.. Cancer chemotherapy and pharmacology, 42(3), 247-249. doi:10.1007/s002800050812
Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma.
Mok, T. S., Steinberg, J., Chan, A. T., Yeo, W. M., Hui, P., Leung, T. W., & Johnson, P. (1998). Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma.. Cancer, 82(12), 2439-2448. doi:3.0.co;2-q">10.1002/(sici)1097-0142(19980615)82:12<2439::aid-cncr19>3.0.co;2-q
Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues.
Chan, J. Y., Chin, W., Liew, C. T., Chang, K. S., & Johnson, P. J. (1998). Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues.. European journal of cancer (Oxford, England : 1990), 34(7), 1015-1022. doi:10.1016/s0959-8049(97)10138-1
Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis.
Ho, S., & Johnson, P. J. (1998). Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis.. British journal of cancer, 77(11), 2059. doi:10.1038/bjc.1998.344
Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
Cheung, S. T., Leung, S. F., Lo, K. W., Chiu, K. W., Tam, J. S., Fok, T. F., . . . Huang, D. P. (1998). Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.. International journal of cancer, 76(3), 399-406. doi:3.0.co;2-6">10.1002/(sici)1097-0215(19980504)76:3<399::aid-ijc18>3.0.co;2-6
Detection of chromosome over- and underrepresentations in hyperdiploid acute lymphoblastic leukemia by comparative genomic hybridization.
Wong, N., Chen, S. J., Cao, Q., Su, X. Y., Niu, C., Wu, Q. W., . . . Chen, Z. (1998). Detection of chromosome over- and underrepresentations in hyperdiploid acute lymphoblastic leukemia by comparative genomic hybridization.. Cancer genetics and cytogenetics, 103(1), 20-24. doi:10.1016/s0165-4608(97)00382-8
The role of chemotherapy in the management of nasopharyngeal carcinoma.
Chan, A. T., Teo, P. M., Leung, T. W., & Johnson, P. J. (1998). The role of chemotherapy in the management of nasopharyngeal carcinoma.. Cancer, 82(6), 1003-1012. doi:3.0.co;2-f">10.1002/(sici)1097-0142(19980315)82:6<1003::aid-cncr1>3.0.co;2-f
Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.
Lau, W. Y., Ho, S., Leung, T. W., Chan, M., Ho, R., Johnson, P. J., & Li, A. K. (1998). Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.. International journal of radiation oncology, biology, physics, 40(3), 583-592. doi:10.1016/s0360-3016(97)00818-3
Controversies in the management of locoregionally advanced nasopharyngeal carcinoma.
Chan, A. T., Teo, P. M., & Johnson, P. J. (1998). Controversies in the management of locoregionally advanced nasopharyngeal carcinoma.. Current opinion in oncology, 10(3), 219-225. doi:10.1097/00001622-199805000-00008
Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate.
Sung, J. J., Yeo, W., Suen, R., Lee, Y. T., Chung, S. C., Chan, F. K., & Johnson, P. J. (1998). Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate.. Gastrointestinal endoscopy, 47(3), 235-239. doi:10.1016/s0016-5107(98)70319-0
New treatment for hepatocellular carcinoma.
Johnson, P. J. (1998). New treatment for hepatocellular carcinoma.. Journal of gastroenterology and hepatology, 13(S3), S311-S314. doi:10.1111/j.1440-1746.1998.tb01900.x
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.
Lo, Y. M., Tein, M. S., Lau, T. K., Haines, C. J., Leung, T. N., Poon, P. M., . . . Hjelm, N. M. (1998). Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.. American journal of human genetics, 62(4), 768-775. doi:10.1086/301800
The significance of keratinizing squamous cell histology in Chinese patients with nasopharyngeal carcinoma.
Chan, A. T., Teo, M. L., Lee, W. Y., Kwan, W. H., Choi, P. H., & Johnson, P. J. (1998). The significance of keratinizing squamous cell histology in Chinese patients with nasopharyngeal carcinoma.. Clinical oncology (Royal College of Radiologists (Great Britain)), 10(3), 161-164. doi:10.1016/s0936-6555(98)80057-5
1997
Arteriovenous shunts in patients with hepatic tumors.
Ho, S., Lau, W. Y., Leung, W. T., Chan, M., Chan, K. W., Johnson, P. J., & Li, A. K. (1997). Arteriovenous shunts in patients with hepatic tumors.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 38(8), 1201-1205.
Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin.
Ho, S., Lau, W. Y., Leung, T. W., Chan, M., Chan, K. W., Lee, W. Y., . . . Li, A. K. (1997). Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin.. The British journal of radiology, 70(836), 823-828. doi:10.1259/bjr.70.836.9486047
Treatment of autoimmune hepatitis.
Johnson, P. J. (1997). Treatment of autoimmune hepatitis.. Gut, 41(1), 3-4. doi:10.1136/gut.41.1.3
Chorionic villus sampling and early amniocentesis for prenatal diagnosis.
Johnson, P. (1997). Chorionic villus sampling and early amniocentesis for prenatal diagnosis.. Lancet (London, England), 349(9062), 1396. doi:10.1016/s0140-6736(05)63236-9
Chorionic villus sampling and early amniocentesis for prenatal diagnosis.
Greenough, A., & Nicolaides, K. H. (1997). Chorionic villus sampling and early amniocentesis for prenatal diagnosis.. Lancet (London, England), 349(9062), 1395-1396. doi:10.1016/s0140-6736(05)63235-7
Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer.
Ho, S., Lau, W. Y., Leung, T. W., Chan, M., Johnson, P. J., & Li, A. K. (1997). Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer.. European journal of nuclear medicine, 24(3), 293-298. doi:10.1007/bf01728766
'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease.
Johnson, P. J., Leung, N., Cheng, P., Welby, C., Leung, W. T., Lau, W. Y., . . . Ho, S. (1997). 'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease.. British journal of cancer, 75(2), 236-240. doi:10.1038/bjc.1997.39
'Spontaneous' regression of advanced leiomyosarcoma of the urinary bladder.
Lei, K. I., Gwi, E., Ma, L., Liang, E. Y., & Johnson, P. J. (1997). 'Spontaneous' regression of advanced leiomyosarcoma of the urinary bladder.. Oncology, 54(1), 19-22. doi:10.1159/000227655
Aggressive primary natural killer cell lymphoma of the caecum: a case report and literature review.
Lei, K. I., Chow, J. H., & Johnson, P. J. (1997). Aggressive primary natural killer cell lymphoma of the caecum: a case report and literature review.. Clinical oncology (Royal College of Radiologists (Great Britain)), 9(3), 191-194. doi:10.1016/s0936-6555(97)80081-7
Assessment of proliferating cell nuclear antigen in nasopharyngeal carcinoma tissue and its relation to clinical findings.
Chan, A. T., Ho, S., Teo, P. M., Tjong, J., Choi, J., Lee, W. Y., . . . Johnson, P. J. (1997). Assessment of proliferating cell nuclear antigen in nasopharyngeal carcinoma tissue and its relation to clinical findings.. Oral oncology, 33(1), 13-18. doi:10.1016/s0964-1955(96)00029-2
Carbamazepine-induced lymphadenopathy mimicking Ki-1 (CD30+) T-cell lymphoma.
Yeo, W., Chow, J., Wong, N., Chan, A. T., & Johnson, P. J. (1997). Carbamazepine-induced lymphadenopathy mimicking Ki-1 (CD30+) T-cell lymphoma.. Pathology, 29(1), 64-66. doi:10.1080/00313029700169564
Cosmetic outcome of breast-conserving therapy in Chinese patients with early breast cancer.
Yeo, W., Kwan, W. H., Teo, P. M., Leung, W. T., King, W., & Johnson, P. J. (1997). Cosmetic outcome of breast-conserving therapy in Chinese patients with early breast cancer.. The Australian and New Zealand journal of surgery, 67(11), 771-774. doi:10.1111/j.1445-2197.1997.tb04577.x
Cyanoacrylate vs sodium tetradecyl sulphate for the injection of bleeding varices in patients with hepatocellular carcinoma: A prospective randomized study
Sung, J. Y., Yoe, W., Suen, R., Chan, K. L., Lee, Y. T., Chung, S. C. S., & Johnson, P. (1997). Cyanoacrylate vs sodium tetradecyl sulphate for the injection of bleeding varices in patients with hepatocellular carcinoma: A prospective randomized study. Gastrointestinal Endoscopy, 45(4), AB85. doi:10.1016/s0016-5107(97)80242-8
Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia.
Mok, T., Koehler, A. P., Yu, M. Y., Ellis, D. H., Johnson, P. J., & Wickham, N. W. (1997). Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia.. Journal of clinical microbiology, 35(10), 2654-2656. doi:10.1128/jcm.35.10.2654-2656.1997
Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis.
Naoumov, N. V., Chokshi, S., Metivier, E., Maertens, G., Johnson, P. J., & Williams, R. (1997). Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis.. Journal of hepatology, 27(2), 331-336. doi:10.1016/s0168-8278(97)80179-1
MRI and CT of metastatic hepatocellular carcinoma causing spinal cord compression.
Yang, W. T., Yeo, W., Leung, S. F., Chan, Y. L., Johnson, P. J., & Metreweli, C. (1997). MRI and CT of metastatic hepatocellular carcinoma causing spinal cord compression.. Clinical radiology, 52(10), 755-760. doi:10.1016/s0009-9260(97)80154-7
Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold.
Yeo, W., Leung, S. F., & Johnson, P. J. (1997). Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold.. European journal of cancer (Oxford, England : 1990), 33(4), 698-699. doi:10.1016/s0959-8049(96)00461-3
Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.
Wong, I. H., Leung, T., Ho, S., Lau, W. Y., Chan, M., & Johnson, P. J. (1997). Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.. British journal of cancer, 76(5), 628-633. doi:10.1038/bjc.1997.436
Transdermal fentanyl for severe cancer-related pain.
Yeo, W., Lam, K. K., Chan, A. T., Leung, T. W., Nip, S. Y., & Johnson, P. J. (1997). Transdermal fentanyl for severe cancer-related pain.. Palliative medicine, 11(3), 233-239. doi:10.1177/026921639701100308
1996
Serum levels of CYFRA 21-1 in nasopharyngeal carcinoma and its possible role in monitoring of therapy.
Ho, S., Leung, W. T., Yuen, J., & Johnson, P. J. (1996). Serum levels of CYFRA 21-1 in nasopharyngeal carcinoma and its possible role in monitoring of therapy.. European journal of cancer. Part B, Oral oncology, 32B(6), 377-380. doi:10.1016/s0964-1955(96)00017-6
The epidemiology of hepatocellular carcinoma.
Johnson, P. J. (1996). The epidemiology of hepatocellular carcinoma.. European journal of gastroenterology & hepatology, 8(9), 845-849.
Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography.
Teo, P., Yu, P., Lee, W. Y., Leung, S. F., Kwan, W. H., Yu, K. H., . . . Johnson, P. J. (1996). Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography.. International journal of radiation oncology, biology, physics, 36(2), 291-304. doi:10.1016/s0360-3016(96)00323-9
Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma.
Yeo, W., Leung, T. W., Leung, S. F., Teo, P. M., Chan, A. T., Lee, W. Y., & Johnson, P. J. (1996). Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma.. Cancer chemotherapy and pharmacology, 38(5), 466-470. doi:10.1007/s002800050512
Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma.
Teo, P. M., Kwan, W. H., Lee, W. Y., Leung, S. F., & Johnson, P. J. (1996). Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma.. Cancer, 77(12), 2423-2431. doi:3.0.co;2-n">10.1002/(sici)1097-0142(19960615)77:12<2423::aid-cncr2>3.0.co;2-n
Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong.
Cheung, S. T., Lo, K. W., Leung, S. F., Chan, W. Y., Choi, P. H., Johnson, P. J., . . . Huang, D. P. (1996). Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong.. International journal of cancer, 66(5), 711-712. doi:3.0.co;2-5">10.1002/(sici)1097-0215(19960529)66:5<711::aid-ijc21>3.0.co;2-5
Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma.
Teo, P. M., Kwan, W. H., Leung, S. F., Leung, W. T., Chan, A., Choi, P., . . . Johnson, P. (1996). Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma.. The British journal of radiology, 69(819), 241-248. doi:10.1259/0007-1285-69-819-241
Small cell variant of Ki-1 lymphoma associated with myelofibrosis and a novel constitutional chromosomal translocation t(3;4) (q13;q12).
Yeo, W., Wong, N., Chow, J., Tsoi, W. C., Johnson, P. J., & Wickham, N. (1996). Small cell variant of Ki-1 lymphoma associated with myelofibrosis and a novel constitutional chromosomal translocation t(3;4) (q13;q12).. Journal of clinical pathology, 49(3), 259-262. doi:10.1136/jcp.49.3.259
Conservative surgery and radiotherapy for early-staged breast cancer
Kwan, W. H., Teo, P. M. L., Yeo, W., Yu, P., Choi, P. H. K., & Johnson, P. J. (1996). Conservative surgery and radiotherapy for early-staged breast cancer. Hong Kong Medical Journal, 2(1), 47-55.
Hepatic angiomyelolipoma and tuberous sclerosis.
Yeo, W., Leong, A., Ward, S. C., Hui, P. K., & Johnson, P. J. (1996). Hepatic angiomyelolipoma and tuberous sclerosis.. Journal of gastroenterology and hepatology, 11(2), 196-198. doi:10.1111/j.1440-1746.1996.tb00061.x
In vitro uptake of bromodeoxyuridine by human nasopharyngeal carcinoma (NPC) and its relation to clinical findings.
Chan, A. T., Ho, S., Teo, P. M., Law, V., Tjong, J., Yu, P., . . . Johnson, P. J. (1996). In vitro uptake of bromodeoxyuridine by human nasopharyngeal carcinoma (NPC) and its relation to clinical findings.. European journal of cancer. Part B, Oral oncology, 32B(1), 50-54. doi:10.1016/0964-1955(95)00057-7
Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.
Ho, S., Cheng, P., Yuen, J., Chan, A., Leung, N., Yeo, W., . . . Johnson, P. J. (1996). Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.. British journal of cancer, 73(8), 985-988. doi:10.1038/bjc.1996.192
Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: an indication for more aggressive treatment.
Kwan, W. H., Teo, P. M., Chow, L. T., Choi, P. H., & Johnson, P. J. (1996). Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: an indication for more aggressive treatment.. Clinical oncology (Royal College of Radiologists (Great Britain)), 8(1), 55-58. doi:10.1016/s0936-6555(05)80041-x
Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices.
Henk, J. M. (1996). Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices.. Clinical oncology (Royal College of Radiologists (Great Britain)), 8(2), 133. doi:10.1016/s0936-6555(96)80133-6
Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.
Ho, S., Lau, W. Y., Leung, T. W., Chan, M., Ngar, Y. K., Johnson, P. J., & Li, A. K. (1996). Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.. European journal of nuclear medicine, 23(8), 947-952. doi:10.1007/bf01084369
Primary mediastinal malignant germ cell tumour. Single institution experience in Chinese patients and correlation with specific alpha-fetoprotein bends.
Chan, A. T., Ho, S., Yim, A. P., Chang, A. R., Cheng, P., Yuen, J., . . . Johnson, P. J. (1996). Primary mediastinal malignant germ cell tumour. Single institution experience in Chinese patients and correlation with specific alpha-fetoprotein bends.. Acta oncologica (Stockholm, Sweden), 35(2), 221-227. doi:10.3109/02841869609098505
Strong association between hyperferritinaemia and metastatic disease in nasopharyngeal carcinoma.
Ho, S., Leung, S. F., Leung, W. T., Tsao, S. Y., Kwan, W. H., Choi, P., & Johnson, P. J. (1996). Strong association between hyperferritinaemia and metastatic disease in nasopharyngeal carcinoma.. European journal of cancer. Part B, Oral oncology, 32B(4), 242-245. doi:10.1016/0964-1955(95)00084-4
Thromboembolic events with paclitaxel.
Chan, A. T., Yeo, W., Leung, W. T., & Johnson, P. J. (1996). Thromboembolic events with paclitaxel.. Clinical oncology (Royal College of Radiologists (Great Britain)), 8(2), 133. doi:10.1016/s0936-6555(96)80134-8
1995
A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinoma.
Yeo, W., Sung, J. Y., Ward, S. C., Chung, S. C., Lee, W. Y., Li, A. K., & Johnson, P. J. (1995). A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinoma.. Digestive diseases and sciences, 40(12), 2516-2521. doi:10.1007/bf02220435
A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.
Chan, A. T., Teo, P. M., Leung, T. W., Leung, S. F., Lee, W. Y., Yeo, W., . . . Johnson, P. J. (1995). A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma.. International journal of radiation oncology, biology, physics, 33(3), 569-577. doi:10.1016/0360-3016(95)00218-n
Azathioprine for long-term maintenance of remission in autoimmune hepatitis.
Johnson, P. J., McFarlane, I. G., & Williams, R. (1995). Azathioprine for long-term maintenance of remission in autoimmune hepatitis.. The New England journal of medicine, 333(15), 958-963. doi:10.1056/nejm199510123331502
Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies.
Lau, W. Y., Leung, W. T., Ho, S., Lam, S. K., Li, C. Y., Johnson, P. J., . . . Li, A. K. (1995). Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies.. Cancer, 75(11), 2669-2676. doi:3.0.co;2-b">10.1002/1097-0142(19950601)75:11<2669::aid-cncr2820751105>3.0.co;2-b
Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma.
Lin, J., Leung, W. T., Ho, S. K., Ho, K. C., Kumta, S. M., Metreweli, C., & Johnson, P. J. (1995). Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma.. European journal of nuclear medicine, 22(6), 553-555. doi:10.1007/bf00817281
Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing.
Johnson, P. J., Ho, S., Cheng, P., Chan, A., Leung, T., & Yuen, J. (1995). Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing.. Cancer, 75(7), 1663-1668. doi:3.0.co;2-o">10.1002/1097-0142(19950401)75:7<1663::aid-cncr2820750717>3.0.co;2-o
A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC).
Teo, P. M., Leung, T. W., Chan, A. T., Yu, P., Lee, W. Y., Leung, S. F., . . . Johnson, P. (1995). A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC).. European journal of cancer. Part B, Oral oncology, 31B(6), 373-379. doi:10.1016/0964-1955(95)00026-7
Extraosseous osteogenic sarcoma of the mediastinum occurring in a Chinese patient.
Lin, J., Ho, J., Chan, A., Yeo, W., Yip, K. M., & Johnson, P. J. (1995). Extraosseous osteogenic sarcoma of the mediastinum occurring in a Chinese patient.. Clinical oncology (Royal College of Radiologists (Great Britain)), 7(3), 200-201. doi:10.1016/s0936-6555(05)80518-7
Nonseminomatous germ cell tumour of testis in Hong Kong Chinese patients.
Chan, A. T., Cheung, M. C., Lau, W. H., Lin, J., Yeo, W., & Johnson, P. J. (1995). Nonseminomatous germ cell tumour of testis in Hong Kong Chinese patients.. Oncology, 52(3), 230-236. doi:10.1159/000227463
Obstructive jaundice secondary to hepatocellular carcinoma.
Lau, W. Y., Leung, K. L., Leung, T. W., Ho, S., Chan, M., Liew, C. K., . . . Li, A. K. (1995). Obstructive jaundice secondary to hepatocellular carcinoma.. Surgical oncology, 4(6), 303-308. doi:10.1016/s0960-7404(10)80042-8
Recombinant human erythropoietin for anaemia in Chinese cancer patients on chemotherapy.
Chan, A. T., Leung, W. T., Lin, J., Yeo, W., & Johnson, P. J. (1995). Recombinant human erythropoietin for anaemia in Chinese cancer patients on chemotherapy.. Clinical oncology (Royal College of Radiologists (Great Britain)), 7(4), 272. doi:10.1016/s0936-6555(05)80622-3
Severe hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone in a patient receiving interferon-alpha for chronic myeloid leukemia.
Lei, K. I., Wickham, N. W., & Johnson, P. J. (1995). Severe hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone in a patient receiving interferon-alpha for chronic myeloid leukemia.. American journal of hematology, 49(1), 100. doi:10.1002/ajh.2830490123
Why can't we cure primary liver cancer?
Johnson, P. J. (1995). Why can't we cure primary liver cancer?. European journal of cancer (Oxford, England : 1990), 31A(10), 1562-1564. doi:10.1016/0959-8049(95)00080-3
1994
Epirubicin in hepatocellular carcinoma: pharmacokinetics and clinical activity.
Dobbs, N. A., Twelves, C. J., Rizzi, P., Warwick, J. D., Metivier, E. M., Williams, R., & Johnson, P. J. (1994). Epirubicin in hepatocellular carcinoma: pharmacokinetics and clinical activity.. Cancer chemotherapy and pharmacology, 34(5), 405-410. doi:10.1007/bf00685565
Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing.
Burditt, L. J., Johnson, M. M., Johnson, P. J., & Williams, R. (1994). Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing.. Cancer, 74(1), 25-29. doi:3.0.co;2-u">10.1002/1097-0142(19940701)74:1<25::aid-cncr2820740106>3.0.co;2-u
Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma.
Teo, P., Leung, S. F., Choi, P., Lee, W. Y., & Johnson, P. J. (1994). Afterloading radiotherapy for local persistence of nasopharyngeal carcinoma.. The British journal of radiology, 67(794), 181-185. doi:10.1259/0007-1285-67-794-181
Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis.
Doherty, D. G., Donaldson, P. T., Underhill, J. A., Farrant, J. M., Duthie, A., Mieli-Vergani, G., . . . Mowat, A. P. (1994). Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis.. Hepatology (Baltimore, Md.), 19(3), 609-615. doi:10.1002/hep.1840190311
Cerebrovascular event following taxol infusion.
Chan, A. T., Leung, W. T., & Johnson, P. J. (1994). Cerebrovascular event following taxol infusion.. Clinical oncology (Royal College of Radiologists (Great Britain)), 6(3), 202-203. doi:10.1016/s0936-6555(94)80062-6
Community prevalence of hepatitis C viraemia: a polymerase chain reaction study.
Sallie, R., King, R., Silva, E., Tibbs, C., Johnson, P., & Williams, R. (1994). Community prevalence of hepatitis C viraemia: a polymerase chain reaction study.. Journal of medical virology, 43(2), 111-114. doi:10.1002/jmv.1890430202
Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma.
Leung, T. W., Lau, W. Y., Ho, S. K., Chan, M., Leung, N. W., Lin, J., . . . Li, A. K. (1994). Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma.. Cancer chemotherapy and pharmacology, 33 Suppl, S33-S36. doi:10.1007/bf00686665
Hazards of interferon treatment in patients with autoimmune chronic active hepatitis.
Farhat, B. A., Johnson, P. J., & Williams, R. (1994). Hazards of interferon treatment in patients with autoimmune chronic active hepatitis.. Journal of hepatology, 20(4), 560-561. doi:10.1016/s0168-8278(05)80507-0
Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin.
Leung, W. T., Lau, W. Y., Ho, S. K., Chan, M., Leung, N. W., Lin, J., . . . Li, A. K. (1994). Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 35(1), 70-73.
Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma: a study based on CT scanning.
Yu, K. H., Teo, P. M., Lee, W. Y., Leung, S. F., Choi, P. H., & Johnson, P. J. (1994). Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma: a study based on CT scanning.. Clinical oncology (Royal College of Radiologists (Great Britain)), 6(3), 167-171. doi:10.1016/s0936-6555(94)80056-1
Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
Leung, W. T., Lau, W. Y., Ho, S., Chan, M., Leung, N., Lin, J., . . . Li, A. K. (1994). Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 35(8), 1313-1318.
Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.
Lei, K. I., Leung, W. T., & Johnson, P. J. (1994). Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.. British journal of cancer, 70(5), 1009-1013. doi:10.1038/bjc.1994.439
Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study.
Lau, W. Y., Leung, W. T., Ho, S., Leung, N. W., Chan, M., Lin, J., . . . Li, A. K. (1994). Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study.. British journal of cancer, 70(5), 994-999. doi:10.1038/bjc.1994.436
1993
Absence of hepatitis C virus in British patients with type 1 autoimmune chronic active hepatitis--a polymerase chain reaction and serological study.
Silva, E., Sallie, R., Tibbs, C., McFarlane, I., Johnson, P., & Williams, R. (1993). Absence of hepatitis C virus in British patients with type 1 autoimmune chronic active hepatitis--a polymerase chain reaction and serological study.. Journal of hepatology, 19(2), 211-215. doi:10.1016/s0168-8278(05)80573-2
Gene expression regulation for interferon-alpha in hepatocellular carcinoma.
d'Arville, C. N., Nouri-Aria, K. T., Johnson, P., & Williams, R. (1993). Gene expression regulation for interferon-alpha in hepatocellular carcinoma.. Journal of hepatology, 17(3), 339-346. doi:10.1016/s0168-8278(05)80215-6
Hepatitis viruses, cirrhosis, and liver cancer.
Johnson, P. J. (1993). Hepatitis viruses, cirrhosis, and liver cancer.. Journal of surgical oncology. Supplement, 3, 28-33. doi:10.1002/jso.2930530509
Meeting report: International Autoimmune Hepatitis Group.
Johnson, P. J., & McFarlane, I. G. (1993). Meeting report: International Autoimmune Hepatitis Group.. Hepatology (Baltimore, Md.), 18(4), 998-1005. doi:10.1002/hep.1840180435
1992
Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters.
Johnson, P. J., Dobbs, N., Kalayci, C., Aldous, M. C., Harper, P., Metivier, E. M., & Williams, R. (1992). Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters.. British journal of cancer, 65(5), 751-755. doi:10.1038/bjc.1992.158
Liver transplantation in carriers of the HBsAg: role of short-term passive prophylaxis with immunoglobulin.
Johnson, P. J. (1992). Liver transplantation in carriers of the HBsAg: role of short-term passive prophylaxis with immunoglobulin.. Journal of hepatology, 14(2-3), 411. doi:10.1016/0168-8278(92)90198-x
[Hilar and peripheral cholangiocarcinomas: clinical, etiologic and molecular characteristics].
Paraf, F. (1992). [Hilar and peripheral cholangiocarcinomas: clinical, etiologic and molecular characteristics].. Gastroenterologie clinique et biologique, 16(10), 822-824.
1991
Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma.
Altaee, M. Y., Johnson, P. J., Farrant, J. M., & Williams, R. (1991). Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma.. Cancer, 68(9), 2051-2055. doi:3.0.co;2-m">10.1002/1097-0142(19911101)68:9<2051::aid-cncr2820680934>3.0.co;2-m
Advances in neoplastic disease of the liver and biliary tract.
Johnson, P. J., Wilkinson, M. L., & Karani, J. (1991). Advances in neoplastic disease of the liver and biliary tract.. Gut, Suppl, S104-S110. doi:10.1136/gut.32.suppl.s104
Chronic active hepatitis.
Johnson, P. J., & McFarlane, I. G. (1991). Chronic active hepatitis.. Gut, Suppl, S63-S72. doi:10.1136/gut.32.suppl.s63
Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.
Hutchinson, W. L., Johnson, P. J., Du, M. Q., & Williams, R. (1991). Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.. Clinical science (London, England : 1979), 81(2), 177-182. doi:10.1042/cs0810177
A comparison of levels of glutathione transferases, cytochromes P450 and acetyltransferases in human livers.
Ketterer, B., Meyer, D. J., Lalor, E., Johnson, P., Guengerich, F. P., Distlerath, L. M., . . . Yamazoe, Y. (1991). A comparison of levels of glutathione transferases, cytochromes P450 and acetyltransferases in human livers.. Biochemical pharmacology, 41(4), 635-638. doi:10.1016/0006-2952(91)90639-m
Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.
Du, M. Q., Hutchinson, W. L., Johnson, P. J., & Williams, R. (1991). Differential alpha-fetoprotein lectin binding in hepatocellular carcinoma. Diagnostic utility at low serum levels.. Cancer, 67(2), 476-480. doi:3.0.co;2-8">10.1002/1097-0142(19910115)67:2<476::aid-cncr2820670226>3.0.co;2-8
Complications
Johnson, P. J. (1991). Complications. Current Opinion in Gastroenterology, 7(3), 401-409. doi:10.1097/00001574-199106000-00011
Epidemiology of hepatocellular carcinoma in the West.
Johnson, P. J. (1992). Epidemiology of hepatocellular carcinoma in the West.. Pathologie-biologie, 39(9), 896-897.
Excellent prognosis in Wilsonian chronic active hepatitis: new data or an article of faith?
Johnson, P. J., & Williams, R. (1991). Excellent prognosis in Wilsonian chronic active hepatitis: new data or an article of faith?. Hepatology (Baltimore, Md.), 14(6), 1293-1295. doi:10.1002/hep.1840140654
Frequency of asymptomatic hepatitis types B and C in an inner city community and relation to possible risk factors.
King, R., Johnson, P. J., White, Y. S., Smith, H. M., & Williams, R. (1991). Frequency of asymptomatic hepatitis types B and C in an inner city community and relation to possible risk factors.. The Quarterly journal of medicine, 80(292), 641-649.
Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis.
Hutchinson, W. L., Du, M. Q., Johnson, P. J., & Williams, R. (1991). Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis.. Hepatology (Baltimore, Md.), 13(4), 683-688. doi:10.1002/hep.1840130412
Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver.
Kalayci, C., Johnson, P. J., Davies, S. E., & Williams, R. (1991). Hepatitis B virus related hepatocellular carcinoma in the non-cirrhotic liver.. Journal of hepatology, 12(1), 54-59. doi:10.1016/0168-8278(91)90909-u
Impaired binding properties of thyroxine-binding globulin in hepatocellular carcinoma and chronic liver disease.
Hutchinson, W. L., White, Y. S., Fagan, E. A., Johnson, P. J., & Williams, R. (1991). Impaired binding properties of thyroxine-binding globulin in hepatocellular carcinoma and chronic liver disease.. Hepatology (Baltimore, Md.), 14(1), 116-120. doi:10.1002/hep.1840140119
Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol.
Johnson, P. J., Kalayci, C., Dobbs, N., Raby, N., Metivier, E. M., Summers, L., . . . Williams, R. (1991). Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol.. Journal of hepatology, 13(1), 120-127. doi:10.1016/0168-8278(91)90873-a
Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.
d'Arville, C. N., Nouri-Aria, K. T., Johnson, P., & Williams, R. (1991). Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.. Hepatology (Baltimore, Md.), 13(2), 310-315. doi:10.1002/hep.1840130217
Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
Donaldson, P. T., Doherty, D. G., Hayllar, K. M., McFarlane, I. G., Johnson, P. J., & Williams, R. (1991). Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.. Hepatology (Baltimore, Md.), 13(4), 701-706. doi:10.1002/hep.1840130415
The natural course and heterogeneity of autoimmune-type chronic active hepatitis.
Johnson, P. J., McFarlane, I. G., & Eddleston, A. L. (1991). The natural course and heterogeneity of autoimmune-type chronic active hepatitis.. Seminars in liver disease, 11(3), 187-196. doi:10.1055/s-2008-1040436
1990
Growth factors, endocrine aspects and hormonal treatment in hepatocellular carcinoma--an overview.
d'Arville, C. N., & Johnson, P. J. (1990). Growth factors, endocrine aspects and hormonal treatment in hepatocellular carcinoma--an overview.. The Journal of steroid biochemistry and molecular biology, 37(6), 1007-1012. doi:10.1016/0960-0760(90)90458-w
Responce
JOHNSON, P. J., & WILLIAMS, R. (1990). Responce. JNCI: Journal of the National Cancer Institute, 82(22), 1784-1785. doi:10.1093/jnci/82.22.1784-a
Hepatitis C antibodies and hepatocellular carcinoma: new clues or a false trail?
Johnson, P. J., & Williams, R. (1990). Hepatitis C antibodies and hepatocellular carcinoma: new clues or a false trail?. Journal of the National Cancer Institute, 82(12), 986-987. doi:10.1093/jnci/82.12.986
Altered plasma and tissue fucosyltransferase activities in hepatocellular carcinoma.
Du, M. Q., Hutchinson, W. L., Johnson, P. J., & Williams, R. (1990). Altered plasma and tissue fucosyltransferase activities in hepatocellular carcinoma.. In Biochemical Society transactions Vol. 18 (pp. 489). doi:10.1042/bst0180489
Differential binding of serum glycoproteins to lectins during hepatic regeneration in hepatocellular carcinoma and fulminant hepatic failure.
Du, M. Q., Hutchinson, W. L., Johnson, P. J., & Williams, R. (1990). Differential binding of serum glycoproteins to lectins during hepatic regeneration in hepatocellular carcinoma and fulminant hepatic failure.. Clinical science (London, England : 1979), 78(6), 551-555. doi:10.1042/cs0780551
Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas.
Zaman, S. N., Johnson, P. J., & Williams, R. (1990). Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas.. Cancer, 65(7), 1607-1610. doi:3.0.co;2-2">10.1002/1097-0142(19900401)65:7<1607::aid-cncr2820650726>3.0.co;2-2
Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?
McFarlane, I. G., Smith, H. M., Johnson, P. J., Bray, G. P., Vergani, D., & Williams, R. (1990). Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?. Lancet (London, England), 335(8692), 754-757. doi:10.1016/0140-6736(90)90870-b
Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies.
Johnson, P. J., McFarlane, I. G., McFarlane, B. M., & Williams, R. (1990). Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies.. Journal of gastroenterology and hepatology, 5(3), 244-251. doi:10.1111/j.1440-1746.1990.tb01624.x
Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
White, Y. S., Johnson, P. J., Davison, F., & Williams, R. (1990). Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.. British journal of cancer, 61(6), 909-912. doi:10.1038/bjc.1990.203
Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin.
Kalayci, C., Johnson, P. J., Raby, N., Metivier, E. M., & Williams, R. (1990). Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin.. Journal of hepatology, 11(3), 349-353. doi:10.1016/0168-8278(90)90220-l
1989
Serum α-fetoprotein and thyroxine-binding globulin in hepatocellular carcinoma
DU, M. -Q., HUTCHINSON, W. L., JOHNSON, P. J., & WILLIAMS, R. (1989). Serum α-fetoprotein and thyroxine-binding globulin in hepatocellular carcinoma. Biochemical Society Transactions, 17(1), 135-136. doi:10.1042/bst0170135
A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma.
Keating, J. J., Johnson, P. J., Cochrane, A. M., Gazzard, B. G., Krasner, N., Smith, P. M., . . . Williams, R. (1989). A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma.. British journal of cancer, 60(5), 789-792. doi:10.1038/bjc.1989.361
Differential hormone-binding characteristics of thyroxine-binding globulin in hepatocellular carcinoma and cirrhosis.
Hutchinson, W. L., Johnson, P. J., White, Y. S., & Williams, R. (1989). Differential hormone-binding characteristics of thyroxine-binding globulin in hepatocellular carcinoma and cirrhosis.. Journal of hepatology, 9(2), 265-271. doi:10.1016/0168-8278(89)90062-7
Role of the standard 'liver function tests' in current clinical practice.
Johnson, P. J. (1989). Role of the standard 'liver function tests' in current clinical practice.. Annals of clinical biochemistry, 26 ( Pt 6), 463-471. doi:10.1177/000456328902600601
1988
Decreased rate of growth of hepatocellular carcinoma recurrence after liver transplantation in patients maintained on cyclosporine immunosuppression.
O'Grady, J. G., Johnson, P. J., Zaman, S., Calne, R. Y., & Williams, R. (1988). Decreased rate of growth of hepatocellular carcinoma recurrence after liver transplantation in patients maintained on cyclosporine immunosuppression.. Transplantation proceedings, 20(3 Suppl 3), 394-396.
Hyperthyroxinaemia in hepatocellular carcinoma: relation to thyroid binding globulin in the clinical and preclinical stages of the disease.
Alexopoulos, A., Hutchinson, W., Bari, A., Keating, J. J., Johnson, P. J., & Williams, R. (1988). Hyperthyroxinaemia in hepatocellular carcinoma: relation to thyroid binding globulin in the clinical and preclinical stages of the disease.. British journal of cancer, 57(3), 313-316. doi:10.1038/bjc.1988.69
Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal.
Stellon, A. J., Keating, J. J., Johnson, P. J., McFarlane, I. G., & Williams, R. (1988). Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal.. Hepatology (Baltimore, Md.), 8(4), 781-784. doi:10.1002/hep.1840080414
1987
The separation of glutathione transferase subunits by using reverse-phase high-pressure liquid chromatography.
Ostlund Farrants, A. K., Meyer, D. J., Coles, B., Southan, C., Aitken, A., Johnson, P. J., & Ketterer, B. (1987). The separation of glutathione transferase subunits by using reverse-phase high-pressure liquid chromatography.. The Biochemical journal, 245(2), 423-428. doi:10.1042/bj2450423
Hepatic sarcomas in adults: a review of 25 cases.
Forbes, A., Portmann, B., Johnson, P., & Williams, R. (1987). Hepatic sarcomas in adults: a review of 25 cases.. Gut, 28(6), 668-674. doi:10.1136/gut.28.6.668
A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report.
Warnes, T. W., Smith, A., Lee, F. I., Haboubi, N. Y., Johnson, P. J., & Hunt, L. (1987). A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report.. Journal of hepatology, 5(1), 1-7. doi:10.1016/s0168-8278(87)80053-3
Another treatment for primary biliary cirrhosis.
Warnes, T. W., Smith, A., Johnson, P. J., Haboubi, N. Y., Babbs, C., & Lee, F. I. (1987). Another treatment for primary biliary cirrhosis.. Gastroenterology, 93(3), 664-665. doi:10.1016/0016-5085(87)90945-0
Cirrhosis and the aetiology of hepatocellular carcinoma.
Johnson, P. J., & Williams, R. (1987). Cirrhosis and the aetiology of hepatocellular carcinoma.. Journal of hepatology, 4(1), 140-147. doi:10.1016/s0168-8278(87)80021-1
Controlled clinical trial of doxorubicin and tamoxifen versus doxorubicin alone in hepatocellular carcinoma.
Melia, W. M., Johnson, P. J., & Williams, R. (1987). Controlled clinical trial of doxorubicin and tamoxifen versus doxorubicin alone in hepatocellular carcinoma.. Cancer treatment reports, 71(12), 1213-1216.
Foreword
Williams, R., & Johnson, P. J. (1987). Foreword. Baillière's Clinical Gastroenterology, 1(1), ix-x. doi:10.1016/0950-3528(87)90030-3
Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients.
Keating, J. J., O'Brien, C. J., Stellon, A. J., Portmann, B. C., Johnson, R. D., Johnson, P. J., & Williams, R. (1987). Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients.. The Quarterly journal of medicine, 62(237), 59-66.
Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5 alpha-dihydrotestosterone.
Forbes, A., Wilkinson, M. L., Iqbal, M. J., Johnson, P. J., & Williams, R. (1987). Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5 alpha-dihydrotestosterone.. European journal of cancer & clinical oncology, 23(11), 1659-1664. doi:10.1016/0277-5379(87)90446-9
The clinical features and natural history of malignant liver tumours.
Johnson, P. J. (1987). The clinical features and natural history of malignant liver tumours.. Bailliere's clinical gastroenterology, 1(1), 17-34. doi:10.1016/0950-3528(87)90032-7
1986
Serum concentrations of sex hormone binding globulin in lung cancer.
Serum concentrations of sex hormone binding globulin in lung cancer. (1986). British medical journal (Clinical research ed.), 293(6556), 1238-1239. doi:10.1136/bmj.293.6556.1238
Serum concentrations of sex hormone binding globulin in lung cancer.
Corbishley, T. P., Keating, J. J., Johnson, P. J., & Williams, R. (1986). Serum concentrations of sex hormone binding globulin in lung cancer.. British medical journal (Clinical research ed.), 293(6550), 791-792. doi:10.1136/bmj.293.6550.791
Vitamin B6 concentrations in patients with chronic liver disease and hepatocellular carcinoma.
Zaman, S. N., Tredger, J. M., Johnson, P. J., & Williams, R. (1986). Vitamin B6 concentrations in patients with chronic liver disease and hepatocellular carcinoma.. British medical journal (Clinical research ed.), 293(6540), 175. doi:10.1136/bmj.293.6540.175
Hepatocellular carcinoma in immigrants to the United Kingdom.
Zaman, S. N., Johnson, P. J., & Williams, R. (1986). Hepatocellular carcinoma in immigrants to the United Kingdom.. The Quarterly journal of medicine, 60(232), 813-817.
Irish endocrine society
Cooper, T. K., Traub, A. I., Magennis, S. D., Nevin, N. C., Darzi, A., Kelly, C. J., . . . Johnson, A. (1986). Irish endocrine society. Irish Journal of Medical Science, 155(9), 335-342. doi:10.1007/bf02960713
Significance of serum bilirubin level in response of hepatocellular carcinoma to doxorubicin.
Johnson, P. J., Alexopoulos, A., Johnson, R. D., & Williams, R. (1986). Significance of serum bilirubin level in response of hepatocellular carcinoma to doxorubicin.. Journal of hepatology, 3(2), 149-153. doi:10.1016/s0168-8278(86)80020-4
Tumour markers in the diagnosis and management of patients with hepatocellular carcinoma.
Johnson, P. J. (1986). Tumour markers in the diagnosis and management of patients with hepatocellular carcinoma.. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 100, 68-72. doi:10.1007/978-3-642-82635-1_8
1985
Clinical course of cirrhosis in young adults and therapeutic potential of liver transplantation.
Keating, J. J., Johnson, R. D., Johnson, P. J., & Williams, R. (1985). Clinical course of cirrhosis in young adults and therapeutic potential of liver transplantation.. Gut, 26(12), 1359-1363. doi:10.1136/gut.26.12.1359
Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients.
Zaman, S. N., Melia, W. M., Johnson, R. D., Portmann, B. C., Johnson, P. J., & Williams, R. (1985). Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients.. Lancet (London, England), 1(8442), 1357-1360. doi:10.1016/s0140-6736(85)91785-4
Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study.
Dunk, A. A., Scott, S. C., Johnson, P. J., Melia, W., Lok, A. S., Murray-Lyon, I., . . . Thomas, H. C. (1985). Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study.. Journal of hepatology, 1(4), 395-404. doi:10.1016/s0168-8278(85)80777-7
Recombinant human gamma-interferon in primary hepatocellular carcinoma.
Forbes, A., Johnson, P. J., & Williams, R. (1985). Recombinant human gamma-interferon in primary hepatocellular carcinoma.. Journal of the Royal Society of Medicine, 78(10), 826-829. doi:10.1177/014107688507801007
1984
Effect of cytotoxic chemotherapy on hepatitis B viral markers in patients with hepatocellular carcinoma.
Zaman, S., Melia, W., Johnson, P., White, Y., & Williams, R. (1984). Effect of cytotoxic chemotherapy on hepatitis B viral markers in patients with hepatocellular carcinoma.. Clinical oncology, 10(3), 247-252.
Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.
Melia, W. M., Wilkinson, M. L., Portmann, B. C., Johnson, P. J., & Williams, R. (1984). Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.. The Quarterly journal of medicine, 53(211), 391-400.
Sex hormones and the liver.
Johnson, P. J. (1984). Sex hormones and the liver.. Clinical science (London, England : 1979), 66(4), 369-376. doi:10.1042/cs0660369
Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.
Melia, W. M., Johnson, P. J., Neuberger, J., Zaman, S., Portmann, B. C., & Williams, R. (1984). Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimation.. Gastroenterology, 87(3), 660-663. doi:10.1016/0016-5085(84)90540-7
Progesterone receptors in malignant and foetal pancreatic tissue
Corbishley, T. P., Iqbal, M. J., Johnson, P. J., & Williams, R. (1984). Progesterone receptors in malignant and foetal pancreatic tissue. IRCS Medical Science, 12(7), 575-576.
Ultrasound determination of liver size and assessment of patients with malignant liver disease.
Raeth, U., Johnson, P. J., & Williams, R. (1984). Ultrasound determination of liver size and assessment of patients with malignant liver disease.. Liver, 4(5), 287-293. doi:10.1111/j.1600-0676.1984.tb00940.x
1983
Sex-steroid enzymes, aromatase and 5 alpha-reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue.
Iqbal, M. J., Greenway, B., Wilkinson, M. L., Johnson, P. J., & Williams, R. (1983). Sex-steroid enzymes, aromatase and 5 alpha-reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue.. Clinical science (London, England : 1979), 65(1), 71-75. doi:10.1042/cs0650071
Serum ferritin in hepatocellular carcinoma. A comparison with alphafetoprotein.
Melia, W. M., Bullock, S., Johnson, P. J., & Williams, R. (1983). Serum ferritin in hepatocellular carcinoma. A comparison with alphafetoprotein.. Cancer, 51(11), 2112-2115. doi:3.0.co;2-6">10.1002/1097-0142(19830601)51:11<2112::aid-cncr2820511126>3.0.co;2-6
Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin.
Melia, W. M., Johnson, P. J., & Williams, R. (1983). Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin.. Cancer, 51(2), 206-210. doi:3.0.co;2-p">10.1002/1097-0142(19830115)51:2<206::aid-cncr2820510206>3.0.co;2-p
Low serum testosterone concentrations in patients with carcinoma of the pancreas.
Greenway, B., Iqbal, M. J., Johnson, P. J., & Williams, R. (1983). Low serum testosterone concentrations in patients with carcinoma of the pancreas.. British medical journal (Clinical research ed.), 286(6359), 93-95. doi:10.1136/bmj.286.6359.93
Sex steroid receptor proteins in foetal, adult and malignant human liver tissue.
Iqbal, M. J., Wilkinson, M. L., Johnson, P. J., & Williams, R. (1983). Sex steroid receptor proteins in foetal, adult and malignant human liver tissue.. British journal of cancer, 48(6), 791-796. doi:10.1038/bjc.1983.268
[Sonographic diagnosis in primary cancer of the liver].
Räth, U., Johnson, P. J., & Williams, R. (1983). [Sonographic diagnosis in primary cancer of the liver].. Der Radiologe, 23(3), 108-113.
1982
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.
Paradinas, F. J., Melia, W. M., Wilkinson, M. L., Portmann, B., Johnson, P. J., Murray-Lyon, I. M., & Williams, R. (1982). High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.. British medical journal (Clinical research ed.), 285(6345), 840-842. doi:10.1136/bmj.285.6345.840
Serum ribonuclease in the diagnosis of pancreatic carcinoma and in monitoring chemotherapy.
Corbishley, T. P., Greenway, B., Johnson, P. J., & Williams, R. (1982). Serum ribonuclease in the diagnosis of pancreatic carcinoma and in monitoring chemotherapy.. Clinica chimica acta; international journal of clinical chemistry, 124(2), 225-233. doi:10.1016/0009-8981(82)90390-4
Oestrogen and Androgen Receptor Proteins in Malignant, Normal, and Foetal Liver in Man
Wilkinson, M. L., Iqbal, M. J., Johnson, P. J., & Williams, R. (1982). Oestrogen and Androgen Receptor Proteins in Malignant, Normal, and Foetal Liver in Man. Clinical Science, 63(3), 65P. doi:10.1042/cs063065pa
Of woodchucks and men: the continuing story of hepatitis B and hepatocellular carcinoma.
Johnson, P. J., & Williams, R. (1982). Of woodchucks and men: the continuing story of hepatitis B and hepatocellular carcinoma.. British medical journal (Clinical research ed.), 284(6329), 1586-1588. doi:10.1136/bmj.284.6329.1586
Pancreatic carcinoma - a sex-steroid responsive tumour?
Greenway, B. A., Iqbal, M. J., Johnson, P. J., & Williams, R. (1982). Pancreatic carcinoma - a sex-steroid responsive tumour?. Proceedings of the American Society of Clinical Oncology, Vol. 1.
Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome.
Melia, W. M., Nunnerley, H. B., Johnson, P. J., & Williams, R. (1982). Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome.. British journal of cancer, 46(3), 331-339. doi:10.1038/bjc.1982.208
1981
Oestrogen receptor proteins in malignant and fetal pancreas.
Greenway, B., Iqbal, M. J., Johnson, P. J., & Williams, R. (1981). Oestrogen receptor proteins in malignant and fetal pancreas.. British medical journal (Clinical research ed.), 283(6294), 751-753. doi:10.1136/bmj.283.6294.751
Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma.
Melia, W. M., Johnson, P. J., Carter, S., Munro-Neville, A., & Williams, R. (1981). Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma.. Cancer, 48(4), 1004-1008. doi:3.0.co;2-d">10.1002/1097-0142(19810815)48:4<1004::aid-cncr2820480425>3.0.co;2-d
Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma.
Johnson, P. J., Melia, W. M., Palmer, M. K., Portmann, B., & Williams, R. (1981). Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma.. British journal of cancer, 44(4), 502-505. doi:10.1038/bjc.1981.218
1980
Serum alpha-foetoprotein in hepatocellular carcinoma--value in diagnosis, and prognosis.
Williams, R., Melia, W. M., & Johnson, P. J. (1980). Serum alpha-foetoprotein in hepatocellular carcinoma--value in diagnosis, and prognosis.. Annals of the Academy of Medicine, Singapore, 9(2), 245-250.
Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: influence of therapy and possible value in early detection.
Johnson, P. J., & Williams, R. (1980). Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: influence of therapy and possible value in early detection.. Journal of the National Cancer Institute, 64(6), 1329-1332. doi:10.1093/jnci/64.6.1329
1979
Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases.
Krasner, N., Johnson, P. J., Portmann, B., Watkinson, G., Macsween, R. N., & Williams, R. (1979). Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases.. Gut, 20(3), 255-258. doi:10.1136/gut.20.3.255
Hepatocellular carcinoma and hepatitis B virus markers in Europe and U.S.A.
Hepatocellular carcinoma and hepatitis B virus markers in Europe and U.S.A. (1979). Lancet (London, England), 1(8113), 433-434. doi:10.1016/s0140-6736(79)90903-6
1978
Liver transplantation in a 27-year-old female with familial HBsAg-positive hepatocellular carcinoma.
Macdougall, B. R., Johnson, P. J., Williams, R., Strunin, L., Macmaster, P., Calne, R. Y., . . . Gips, C. H. (1978). Liver transplantation in a 27-year-old female with familial HBsAg-positive hepatocellular carcinoma.. The Netherlands journal of medicine, 21(3), 101-116.
Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.
Johnson, P. J., Krasner, N., Portmann, B., Eddleston, A. L., & Williams, R. (1978). Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.. Gut, 19(11), 1022-1026. doi:10.1136/gut.19.11.1022
Induction of remission in hepatocellular carcinoma with doxorubicin.
Johnson, P. J., Williams, R., Thomas, H., Sherlock, S., & Murray-Lyon, I. M. (1978). Induction of remission in hepatocellular carcinoma with doxorubicin.. Lancet (London, England), 1(8072), 1006-1009. doi:10.1016/s0140-6736(78)90735-3
Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin.
Johnson, P. J., Wansbrough-Jones, M. H., Portmann, B., Eddleston, A. L., Williams, R., Maycook, W. D., & Calne, R. Y. (1978). Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin.. British medical journal, 1(6107), 216. doi:10.1136/bmj.1.6107.216
Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin.
Johnson, P. J., Wansbrough-Jones, M. H., Portmann, B., Eddleston, A. L., Williams, R., Maycook, W. D., & Calne, R. Y. (1978). Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin.. BMJ, 1(6107), 216. doi:10.1136/bmj.1.6107.216
Characteristics of serum alpha fetoprotein response to therapy in patients with hepatocellular carcinoma
Johnson, P. J., & Williams, R. (1978). Characteristics of serum alpha fetoprotein response to therapy in patients with hepatocellular carcinoma. Italian Journal of Gastroenterology, 10(3).
1977
Reptilase time in cirrhosis and hepatocellular carcinoma
Reptilase time in cirrhosis and hepatocellular carcinoma (1977). BMJ, 2(6093), 1035.3-1035. doi:10.1136/bmj.2.6093.1035-b
Reptilase time in cirrhosis and hepatocellular carcinoma.
Johnson, P. J., White, Y., Woolf, I. L., & Williams, R. (1977). Reptilase time in cirrhosis and hepatocellular carcinoma.. British medical journal, 2(6091), 869-870. doi:10.1136/bmj.2.6091.869-a
Induction of remission in hepatocellular carcinoma with adriamycin
Johnson, P. J., Williams, R., & Thomas, H. (1977). Induction of remission in hepatocellular carcinoma with adriamycin. Gut, 18(11).
Vitamin B<inf>12</inf> binding protein in hepatocellular carcinoma: value in monitoring therapy
Kane, S. P., Kohn, J., & Johnson, P. (1977). Vitamin B<inf>12</inf> binding protein in hepatocellular carcinoma: value in monitoring therapy. Gut, 18(11).
1976
Proceedings: Hepatoma in chronic liver disease.
Krasner, N., Johnson, P., Bomford, A., Eddleston, A. L., & Williams, R. (1976). Proceedings: Hepatoma in chronic liver disease.. Gut, 17(5), 390.